{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 44732, "items": [{"indexed": {"date-parts": [[2018, 9, 13]], "date-time": "2018-09-13T08:22:34Z", "timestamp": 1536826954455}, "reference-count": 23, "publisher": "Springer Nature", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2011, 6]]}, "DOI": "10.1007/s10549-011-1441-2", "type": "journal-article", "created": {"date-parts": [[2011, 3, 16]], "date-time": "2011-03-16T08:15:38Z", "timestamp": 1300263338000}, "page": "861-869", "source": "Crossref", "is-referenced-by-count": 50, "title": ["PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy"], "prefix": "10.1007", "volume": "127", "author": [{"given": "Pawel", "family": "Domagala", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}, {"given": "Karol", "family": "Gugala", "sequence": "additional", "affiliation": []}, {"given": "Wenancjusz", "family": "Domagala", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 3, 17]]}, "reference": [{"key": "1441_CR1", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1038/nrm1963", "volume": "7", "author": "V Schreiber", "year": "2006", "unstructured": "Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517\u2013528", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "1441_CR2", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1038/nature03445", "volume": "434", "author": "H Farmer", "year": "2005", "unstructured": "Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917\u2013921", "journal-title": "Nature"}, {"key": "1441_CR3", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1038/nature03443", "volume": "434", "author": "HE Bryant", "year": "2005", "unstructured": "Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913\u2013917", "journal-title": "Nature"}, {"key": "1441_CR4", "doi-asserted-by": "crossref", "first-page": "3916", "DOI": "10.1158/1078-0432.CCR-07-4953", "volume": "14", "author": "B Evers", "year": "2008", "unstructured": "Evers B, Drost R, Schut E, de Bruin M, van der Burg E, Derksen PW, Holstege H, Liu X, van Drunen E, Beverloo HB, Smith GC, Martin NM, Lau A, O\u2019Connor MJ, Jonkers J (2008) Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin. Clin Cancer Res 14:3916\u20133925", "journal-title": "Clin Cancer Res"}, {"key": "1441_CR5", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/j.drup.2007.11.002", "volume": "11", "author": "S Rottenberg", "year": "2008", "unstructured": "Rottenberg S, Jonkers J (2008) Modeling therapy resistance in genetically engineered mouse cancer models. Drug Resist Updat 11:51\u201360", "journal-title": "Drug Resist Updat"}, {"key": "1441_CR6", "doi-asserted-by": "crossref", "first-page": "3850", "DOI": "10.1158/0008-5472.CAN-08-2388", "volume": "69", "author": "T Hay", "year": "2009", "unstructured": "Hay T, Matthews JR, Pietzka L, Lau A, Cranston A, Nygren AO, Douglas-Jones A, Smith GC, Martin NM, O\u2019Connor M, Clarke AR (2009) Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin. Cancer Res 69:3850\u20133855", "journal-title": "Cancer Res"}, {"key": "1441_CR7", "first-page": "55", "volume": "24", "author": "EA Comen", "year": "2010", "unstructured": "Comen EA, Robson M (2010) Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. Oncology (Williston Park) 24:55\u201362", "journal-title": "Oncology (Williston Park)"}, {"key": "1441_CR8", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1056/NEJMoa0900212", "volume": "361", "author": "PC Fong", "year": "2009", "unstructured": "Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O\u2019Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361:123\u2013134", "journal-title": "N Engl J Med"}, {"key": "1441_CR9", "doi-asserted-by": "crossref", "first-page": "2374", "DOI": "10.1016/j.ejca.2006.01.061", "volume": "42", "author": "K Nosho", "year": "2006", "unstructured": "Nosho K, Yamamoto H, Mikami M, Taniguchi H, Takahashi T, Adachi Y, Imamura A, Imai K, Shinomura Y (2006) Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer 42:2374\u20132381", "journal-title": "Eur J Cancer"}, {"key": "1441_CR10", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1007/s12253-008-9086-0", "volume": "15", "author": "B Csete", "year": "2009", "unstructured": "Csete B, Lengyel Z, Kadar Z, Battyani Z (2009) Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor. Pathol Oncol Res 15:47\u201353", "journal-title": "Pathol Oncol Res"}, {"key": "1441_CR11", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1007/s10549-005-1409-1", "volume": "92", "author": "B Gorski", "year": "2005", "unstructured": "Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbanski K, Mitus J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Toloczko-Grabarek A, Medrek K, Masojc B, Mierzejewski M, Kowalska E, Narod SA, Lubinski J (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92:19\u201324", "journal-title": "Breast Cancer Res Treat"}, {"key": "1441_CR12", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1111/j.1365-2559.1991.tb00229.x", "volume": "19", "author": "CW Elston", "year": "1991", "unstructured": "Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403\u2013410", "journal-title": "Histopathology"}, {"key": "1441_CR13", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1038/bjc.1982.62", "volume": "45", "author": "JL Haybittle", "year": "1982", "unstructured": "Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361\u2013366", "journal-title": "Br J Cancer"}, {"key": "1441_CR14", "doi-asserted-by": "crossref", "first-page": "876", "DOI": "10.1136/jcp.48.9.876", "volume": "48", "author": "S Detre", "year": "1995", "unstructured": "Detre S, Saclani Jotti G, Dowsett M (1995) A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48:876\u2013878", "journal-title": "J Clin Pathol"}, {"key": "1441_CR15", "first-page": "18", "volume": "131", "author": "AC Wolff", "year": "2007", "unstructured": "Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18\u201343", "journal-title": "Arch Pathol Lab Med"}, {"key": "1441_CR16", "first-page": "E1", "volume": "134", "author": "ME Hammond", "year": "2010", "unstructured": "Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:E1\u2013E16", "journal-title": "Arch Pathol Lab Med"}, {"key": "1441_CR17", "doi-asserted-by": "crossref", "first-page": "5367", "DOI": "10.1158/1078-0432.CCR-04-0220", "volume": "10", "author": "TO Nielsen", "year": "2004", "unstructured": "Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367\u20135374", "journal-title": "Clin Cancer Res"}, {"key": "1441_CR18", "doi-asserted-by": "crossref", "first-page": "1368", "DOI": "10.1158/1078-0432.CCR-07-1658", "volume": "14", "author": "MC Cheang", "year": "2008", "unstructured": "Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14:1368\u20131376", "journal-title": "Clin Cancer Res"}, {"key": "1441_CR19", "doi-asserted-by": "crossref", "first-page": "1583", "DOI": "10.1021/pr0501158", "volume": "4", "author": "Z Fu", "year": "2005", "unstructured": "Fu Z, Fenselau C (2005) Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance. J Proteome Res 4:1583\u20131591", "journal-title": "J Proteome Res"}, {"key": "1441_CR20", "doi-asserted-by": "crossref", "first-page": "1465", "DOI": "10.1038/onc.2008.483", "volume": "28", "author": "N McCabe", "year": "2009", "unstructured": "McCabe N, Cerone MA, Ohishi T, Seimiya H, Lord CJ, Ashworth A (2009) Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene 28:1465\u20131470", "journal-title": "Oncogene"}, {"key": "1441_CR21", "first-page": "1163", "volume": "2", "author": "I Bieche", "year": "1996", "unstructured": "Bieche I, de Murcia G, Lidereau R (1996) Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res 2:1163\u20131167", "journal-title": "Clin Cancer Res"}, {"key": "1441_CR22", "doi-asserted-by": "crossref", "first-page": "2126", "DOI": "10.1038/sj.onc.1210014", "volume": "26", "author": "NC Turner", "year": "2007", "unstructured": "Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, Savage K, Gillett CE, Schmitt FC, Ashworth A, Tutt AN (2007) BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26:2126\u20132132", "journal-title": "Oncogene"}, {"key": "1441_CR23", "doi-asserted-by": "crossref", "first-page": "R78", "DOI": "10.1186/bcr2445", "volume": "11", "author": "D Inbar-Rozensal", "year": "2009", "unstructured": "Inbar-Rozensal D, Castiel A, Visochek L, Castel D, Dantzer F, Izraeli S, Cohen-Armon M (2009) A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors. Breast Cancer Res 11:R78", "journal-title": "Breast Cancer Res"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-011-1441-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T21:06:45Z", "timestamp": 1497906405000}, "score": 18.57933, "issued": {"date-parts": [[2011, 3, 17]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2011, 6]]}, "issue": "3"}, "alternative-id": ["1441"], "URL": "http://dx.doi.org/10.1007/s10549-011-1441-2", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 9, 26]], "date-time": "2018-09-26T14:22:48Z", "timestamp": 1537971768285}, "reference-count": 53, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Virchows Arch"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1007/s00428-010-0988-3", "type": "journal-article", "created": {"date-parts": [[2010, 10, 13]], "date-time": "2010-10-13T17:38:10Z", "timestamp": 1286991490000}, "page": "55-64", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Immunophenotypic predictive profiling of BRCA1-associated breast cancer"], "prefix": "10.1007", "volume": "458", "author": [{"given": "Pawel", "family": "Domagala", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}, {"given": "Karol", "family": "Gugala", "sequence": "additional", "affiliation": []}, {"given": "Wenancjusz", "family": "Domagala", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 10, 13]]}, "reference": [{"key": "988_CR1", "first-page": "2339", "volume": "348", "author": "R Wooster", "year": "2003", "unstructured": "Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348:2339\u20132347", "journal-title": "N Engl J Med"}, {"key": "988_CR2", "first-page": "609", "volume": "20", "author": "J Fasano", "year": "2009", "unstructured": "Fasano J, Muggia F (2009) Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development. Ann Oncol 20:609\u2013614", "journal-title": "Ann Oncol"}, {"key": "988_CR3", "first-page": "55", "volume": "24", "author": "EA Comen", "year": "2010", "unstructured": "Comen EA, Robson M (2010) Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. Oncology (Williston Park) 24:55\u201362", "journal-title": "Oncology (Williston Park)"}, {"key": "988_CR4", "first-page": "206", "volume": "36", "author": "A Bosch", "year": "2010", "unstructured": "Bosch A, Eroles P, Zaragoza R, Vina JR, Lluch A (2010) Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. Cancer Treat Rev 36:206\u2013215", "journal-title": "Cancer Treat Rev"}, {"key": "988_CR5", "first-page": "2310", "volume": "20", "author": "SR Lakhani", "year": "2002", "unstructured": "Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310\u20132318", "journal-title": "J Clin Oncol"}, {"key": "988_CR6", "first-page": "5175", "volume": "11", "author": "SR Lakhani", "year": "2005", "unstructured": "Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Kramling C, Daly PA, Haites N, Varley J, Lalloo F, Evans G, Maugard C, Meijers-Heijboer H, Klijn JG, Olah E, Gusterson BA, Pilotti S, Radice P, Scherneck S, Sobol H, Jacquemier J, Wagner T, Peto J, Stratton MR, McGuffog L, Easton DF, Breast Cancer Linkage Consortium (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11:5175\u20135180", "journal-title": "Clin Cancer Res"}, {"key": "988_CR7", "first-page": "391", "volume": "17", "author": "CT Brekelmans", "year": "2006", "unstructured": "Brekelmans CT, Seynaeve C, Menke-Pluymers M, Bruggenwirth HT, Tilanus-Linthorst MM, Bartels CC, Kriege M, van Geel AN, Crepin CM, Blom JC, Meijers-Heijboer H, Klijn JG (2006) Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol 17:391\u2013400", "journal-title": "Ann Oncol"}, {"key": "988_CR8", "first-page": "519", "volume": "454", "author": "M Graeser", "year": "2009", "unstructured": "Graeser M, Bosse K, Brosig M, Engel C, Schmutzler RK, German Consortium for Hereditary Breast and Ovarian Cancer (2009) Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer. Virchows Arch 454:519\u2013524", "journal-title": "Virchows Arch"}, {"key": "988_CR9", "first-page": "R12", "volume": "12", "author": "N Tung", "year": "2010", "unstructured": "Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, Comander AH, Gallagher B, Fetten K, Krag K, Stoeckert KA, Legare RD, Sgroi D, Ryan PD, Garber JE, Schnitt SJ (2010) Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res 12:R12", "journal-title": "Breast Cancer Res"}, {"key": "988_CR10", "first-page": "19", "volume": "92", "author": "B Gorski", "year": "2005", "unstructured": "Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbanski K, Mitus J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Toloczko-Grabarek A, Medrek K, Masojc B, Mierzejewski M, Kowalska E, Narod SA, Lubinski J (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92:19\u201324", "journal-title": "Breast Cancer Res Treat"}, {"key": "988_CR11", "first-page": "403", "volume": "19", "author": "CW Elston", "year": "1991", "unstructured": "Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403\u2013410", "journal-title": "Histopathology"}, {"key": "988_CR12", "first-page": "876", "volume": "48", "author": "S Detre", "year": "1995", "unstructured": "Detre S, Saclani Jotti G, Dowsett M (1995) A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48:876\u2013878", "journal-title": "J Clin Pathol"}, {"key": "988_CR13", "first-page": "18", "volume": "131", "author": "AC Wolff", "year": "2007", "unstructured": "Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncology/College of American Pathologists (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18\u201343", "journal-title": "Arch Pathol Lab Med"}, {"key": "988_CR14", "first-page": "907", "volume": "134", "author": "ME Hammond", "year": "2010", "unstructured": "Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:907\u2013922", "journal-title": "Arch Pathol Lab Med"}, {"key": "988_CR15", "first-page": "33", "volume": "83", "author": "P Ulivi", "year": "2004", "unstructured": "Ulivi P, Zoli W, Medri L, Amadori D, Saragoni L, Barbanti F, Calistri D, Silvestrini R (2004) c-kit and SCF expression in normal and tumor breast tissue. Breast Cancer Res Treat 83:33\u201342", "journal-title": "Breast Cancer Res Treat"}, {"key": "988_CR16", "first-page": "359", "volume": "115", "author": "T Byrski", "year": "2009", "unstructured": "Byrski T, Huzarski T, Dent R, Gronwald J, Zuziak D, Cybulski C, Kladny J, Gorski B, Lubinski J, Narod SA (2009) Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 115:359\u2013363", "journal-title": "Breast Cancer Res Treat"}, {"key": "988_CR17", "first-page": "23899", "volume": "275", "author": "A Bhattacharyya", "year": "2000", "unstructured": "Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR, Bishop DK (2000) The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 275:23899\u201323903", "journal-title": "J Biol Chem"}, {"key": "988_CR18", "first-page": "517", "volume": "7", "author": "V Schreiber", "year": "2006", "unstructured": "Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517\u2013528", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "988_CR19", "first-page": "917", "volume": "434", "author": "H Farmer", "year": "2005", "unstructured": "Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917\u2013921", "journal-title": "Nature"}, {"key": "988_CR20", "first-page": "913", "volume": "434", "author": "HE Bryant", "year": "2005", "unstructured": "Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913\u2013917", "journal-title": "Nature"}, {"key": "988_CR21", "first-page": "123", "volume": "361", "author": "PC Fong", "year": "2009", "unstructured": "Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O\u2019Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361:123\u2013134", "journal-title": "N Engl J Med"}, {"key": "988_CR22", "first-page": "235", "volume": "376", "author": "A Tutt", "year": "2010", "unstructured": "Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376:235\u2013244", "journal-title": "Lancet"}, {"key": "988_CR23", "first-page": "1583", "volume": "4", "author": "Z Fu", "year": "2005", "unstructured": "Fu Z, Fenselau C (2005) Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance. J Proteome Res 4:1583\u20131591", "journal-title": "J Proteome Res"}, {"key": "988_CR24", "first-page": "7303", "volume": "94", "author": "JM Murcia de", "year": "1997", "unstructured": "de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci U S A 94:7303\u20137307", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "988_CR25", "first-page": "2644", "volume": "26", "author": "C Trucco", "year": "1998", "unstructured": "Trucco C, Oliver FJ, de Murcia G, Menissier-de Murcia J (1998) DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Res 26:2644\u20132649", "journal-title": "Nucleic Acids Res"}, {"key": "988_CR26", "first-page": "227", "volume": "51", "author": "CK Osborne", "year": "1998", "unstructured": "Osborne CK (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51:227\u2013238", "journal-title": "Breast Cancer Res Treat"}, {"key": "988_CR27", "first-page": "2251", "volume": "286", "author": "MC King", "year": "2001", "unstructured": "King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B, National Surgical Adjuvant Breast and Bowel Project (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 286:2251\u20132256", "journal-title": "JAMA"}, {"key": "988_CR28", "first-page": "1683", "volume": "99", "author": "AM Hosey", "year": "2007", "unstructured": "Hosey AM, Gorski JJ, Murray MM, Quinn JE, Chung WY, Stewart GE, James CR, Farragher SM, Mulligan JM, Scott AN, Dervan PA, Johnston PG, Couch FJ, Daly PA, Kay E, McCann A, Mullan PB, Harkin DP (2007) Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J Natl Cancer Inst 99:1683\u20131694", "journal-title": "J Natl Cancer Inst"}, {"key": "988_CR29", "first-page": "320", "volume": "14", "author": "JS Ross", "year": "2009", "unstructured": "Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14:320\u2013368", "journal-title": "Oncologist"}, {"key": "988_CR30", "first-page": "417", "volume": "8", "author": "F Milanezi", "year": "2008", "unstructured": "Milanezi F, Carvalho S, Schmitt FC (2008) EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy. Expert Rev Mol Diagn 8:417\u2013434", "journal-title": "Expert Rev Mol Diagn"}, {"key": "988_CR31", "first-page": "907", "volume": "15", "author": "E Lim", "year": "2009", "unstructured": "Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, kConFab, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15:907\u2013913", "journal-title": "Nat Med"}, {"key": "988_CR32", "first-page": "362", "volume": "33", "author": "OT Johannsson", "year": "1997", "unstructured": "Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, Egilsson V, Olsson H (1997) Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 33:362\u2013371", "journal-title": "Eur J Cancer"}, {"key": "988_CR33", "first-page": "1140", "volume": "29", "author": "BJ Lynch", "year": "1998", "unstructured": "Lynch BJ, Holden JA, Buys SS, Neuhausen SL, Gaffney DK (1998) Pathobiologic characteristics of hereditary breast cancer. Hum Pathol 29:1140\u20131144", "journal-title": "Hum Pathol"}, {"key": "988_CR34", "first-page": "1683", "volume": "34", "author": "P Osin", "year": "1998", "unstructured": "Osin P, Gusterson BA, Philp E, Waller J, Bartek J, Peto J, Crook T (1998) Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers. Eur J Cancer 34:1683\u20131686", "journal-title": "Eur J Cancer"}, {"key": "988_CR35", "first-page": "263", "volume": "84", "author": "F Eisinger", "year": "1999", "unstructured": "Eisinger F, Nogues C, Guinebretiere JM, Peyrat JP, Bardou VJ, Noguchi T, Vennin P, Sauvan R, Lidereau R, Birnbaum D, Jacquemier J, Sobol H (1999) Novel indications for BRCA1 screening using individual clinical and morphological features. Int J Cancer 84:263\u2013267", "journal-title": "Int J Cancer"}, {"key": "988_CR36", "first-page": "1937", "volume": "7", "author": "SA Vaziri", "year": "2001", "unstructured": "Vaziri SA, Krumroy LM, Elson P, Budd GT, Darlington G, Myles J, Tubbs RR, Casey G (2001) Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. Clin Cancer Res 7:1937\u20131945", "journal-title": "Clin Cancer Res"}, {"key": "988_CR37", "first-page": "1481", "volume": "62", "author": "TA Grushko", "year": "2002", "unstructured": "Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, Sanders MO, Weber BL, Olopade OI (2002) Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res 62:1481\u20131488", "journal-title": "Cancer Res"}, {"key": "988_CR38", "first-page": "2068", "volume": "95", "author": "LA Quenneville", "year": "2002", "unstructured": "Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, Andrulis IL, O\u2019Malley FP (2002) HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer 95:2068\u20132075", "journal-title": "Cancer"}, {"key": "988_CR39", "first-page": "527", "volume": "97", "author": "JR Goffin", "year": "2003", "unstructured": "Goffin JR, Chappuis PO, Begin LR, Wong N, Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD (2003) Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data. Cancer 97:527\u2013536", "journal-title": "Cancer"}, {"key": "988_CR40", "first-page": "2029", "volume": "10", "author": "WD Foulkes", "year": "2004", "unstructured": "Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Begin LR, Narod SA (2004) Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clin Cancer Res 10:2029\u20132034", "journal-title": "Clin Cancer Res"}, {"key": "988_CR41", "first-page": "71", "volume": "99", "author": "J Lubinski", "year": "2006", "unstructured": "Lubinski J, Gorski B, Huzarski T, Byrski T, Gronwald J, Serrano-Fernandez P, Domagala W, Chosia M, Ucinski M, Grzybowska E, Lange D, Maka B, Mackiewicz A, Karczewska A, Breborowicz J, Lamperska K, Stawicka M, Gozdecka-Grodecka S, Bebenek M, Sorokin D, Wojnar A, Haus O, Sir J, Mierzwa T, Niepsuj S, Gugala K, Gozdz S, Sygut J, Kozak-Klonowska B, Musiatowicz B, Posmyk M, Kordek R, Morawiec M, Zambrano O, Wasko B, Fudali L, Skret J, Surdyka D, Urbanski K, Mitus J, Rys J, Szwiec M, Rozmiarek A, Dziuba I, Wandzel P, Wisniowski R, Szczylik C, Kozak A, Kozlowski W, Narod SA (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat 99:71\u201376", "journal-title": "Breast Cancer Res Treat"}, {"key": "988_CR42", "first-page": "1693", "volume": "12", "author": "RA Oldenburg", "year": "2006", "unstructured": "Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P (2006) Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. Clin Cancer Res 12:1693\u20131700", "journal-title": "Clin Cancer Res"}, {"key": "988_CR43", "first-page": "611", "volume": "59", "author": "P Groep van der", "year": "2006", "unstructured": "van der Groep P, Bouter A, van der Zanden R, Siccama I, Menko FH, Gille JJ, van Kalken C, van der Wall E, Verheijen RH, van Diest PJ (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59:611\u2013617", "journal-title": "J Clin Pathol"}, {"key": "988_CR44", "first-page": "199", "volume": "46", "author": "AI Hagen", "year": "2007", "unstructured": "Hagen AI, Bofin AM, Ytterhus B, Maehle LO, Kjellevold KH, Myhre HO, Moller P, Lonning PE (2007) Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations. Acta Oncol 46:199\u2013203", "journal-title": "Acta Oncol"}, {"key": "988_CR45", "first-page": "1298", "volume": "20", "author": "E Honrado", "year": "2007", "unstructured": "Honrado E, Osorio A, Milne RL, Paz MF, Melchor L, Cascon A, Urioste M, Cazorla A, Diez O, Lerma E, Esteller M, Palacios J, Benitez J (2007) Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pathol 20:1298\u20131306", "journal-title": "Mod Pathol"}, {"key": "988_CR46", "first-page": "4282", "volume": "26", "author": "DP Atchley", "year": "2008", "unstructured": "Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, Gonzalez-Angulo AM, Hortobagyi GN, Arun BK (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26:4282\u20134288", "journal-title": "J Clin Oncol"}, {"key": "988_CR47", "first-page": "1976", "volume": "14", "author": "K Aaltonen", "year": "2008", "unstructured": "Aaltonen K, Blomqvist C, Amini RM, Eerola H, Aittomaki K, Heikkila P, Nevanlinna H (2008) Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers. Clin Cancer Res 14:1976\u20131983", "journal-title": "Clin Cancer Res"}, {"key": "988_CR48", "first-page": "100", "volume": "8", "author": "MM Litwiniuk", "year": "2008", "unstructured": "Litwiniuk MM, Roznowski K, Filas V, Godlewski DD, Stawicka M, Kaleta R, Breborowicz J (2008) Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers. BMC Cancer 8:100", "journal-title": "BMC Cancer"}, {"key": "988_CR49", "first-page": "1093", "volume": "33", "author": "LC Collins", "year": "2009", "unstructured": "Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE (2009) Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol 33:1093\u20131097", "journal-title": "Am J Surg Pathol"}, {"key": "988_CR50", "first-page": "811", "volume": "46", "author": "DG Evans", "year": "2009", "unstructured": "Evans DG, Lalloo F, Cramer A, Jones EA, Knox F, Amir E, Howell A (2009) Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46:811\u2013817", "journal-title": "J Med Genet"}, {"key": "988_CR51", "first-page": "63", "volume": "3", "author": "A Kwong", "year": "2009", "unstructured": "Kwong A, Wong LP, Wong HN, Law FB, Ng EK, Tang YH, Chan WK, Suen DT, Choi C, Ho LS, Kwan KH, Poon M, Wong TT, Chan K, Chan SW, Ying MW, Chan WC, Ma ES, Ford JM, West DW (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3:63\u201376", "journal-title": "Hugo J"}, {"key": "988_CR52", "first-page": "663", "volume": "69", "author": "E Manie", "year": "2009", "unstructured": "Manie E, Vincent-Salomon A, Lehmann-Che J, Pierron G, Turpin E, Warcoin M, Gruel N, Lebigot I, Sastre-Garau X, Lidereau R, Remenieras A, Feunteun J, Delattre O, de The H, Stoppa-Lyonnet D, Stern MH (2009) High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res 69:663\u2013671", "journal-title": "Cancer Res"}, {"key": "988_CR53", "first-page": "479", "volume": "116", "author": "SA Joosse", "year": "2009", "unstructured": "Joosse SA, van Beers EH, Tielen IH, Horlings H, Peterse JL, Hoogerbrugge N, Ligtenberg MJ, Wessels LF, Axwijk P, Verhoef S, Hogervorst FB, Nederlof PM (2009) Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. Breast Cancer Res Treat 116:479\u2013489", "journal-title": "Breast Cancer Res Treat"}], "container-title": ["Virchows Archiv"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s00428-010-0988-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2013, 3, 24]], "date-time": "2013-03-24T13:22:25Z", "timestamp": 1364131345000}, "score": 18.57933, "issued": {"date-parts": [[2010, 10, 13]]}, "references-count": 53, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "1"}, "alternative-id": ["988"], "URL": "http://dx.doi.org/10.1007/s00428-010-0988-3", "relation": {"cites": []}, "ISSN": ["0945-6317", "1432-2307"], "issn-type": [{"value": "0945-6317", "type": "print"}, {"value": "1432-2307", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T00:30:05Z", "timestamp": 1525480205323}, "reference-count": 12, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2006, 5]]}, "DOI": "10.1007/s10549-005-9097-4", "type": "journal-article", "created": {"date-parts": [[2005, 11, 30]], "date-time": "2005-11-30T16:18:00Z", "timestamp": 1133367480000}, "page": "113-114", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Male to female ratio among offspring of BRCA1 mutation carriers"], "prefix": "10.1007", "volume": "97", "author": [{"given": "Jacek", "family": "Gronwald", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Steven A.", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 12, 1]]}, "reference": [{"key": "9097_CR1", "first-page": "393", "volume": "111", "author": "S Ganesan", "year": "2002", "unstructured": "Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM, BRCA1 supports XIST RNA concentration on the inactive X chromosomeCell 2002; 111:393\u2013405", "journal-title": "Cell"}, {"key": "9097_CR2", "first-page": "195", "volume": "32", "author": "JT Lee", "year": "2002", "unstructured": "Lee JT., Homozygous Tsix mutant mice reveal a sex-ratio distortion and revert to random X-inactivationNat Genet 2002; 32:195\u2013200", "journal-title": "Nat Genet"}, {"key": "9097_CR3", "first-page": "339", "volume": "91", "author": "RE Buller", "year": "1999", "unstructured": "Buller RE, Sood AK, Lallas T, Buekers T, Skilling JS, Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst 1999; 91:339\u2013346", "journal-title": "J Natl Cancer Inst"}, {"key": "9097_CR4", "first-page": "929", "volume": "290", "author": "M la Hoya de", "year": "2003", "unstructured": "de la Hoya M, Fernandez JM, Tosar A, Godino J, Sanchez de Abajo A, Vidart JA, Perez-Segura P, Diaz-Rubio E, Caldes T Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or bothJAMA 2003; 290:929\u2013931", "journal-title": "JAMA"}, {"key": "9097_CR5", "first-page": "2544", "volume": "290", "author": "ME Mealiffe", "year": "2003", "unstructured": "Mealiffe ME Sex ratios in families with BRCA mutationsJAMA2003; 290:2544", "journal-title": "JAMA"}, {"key": "9097_CR6", "first-page": "687", "volume": "292", "author": "J Feunteun", "year": "2004", "unstructured": "Feunteun J, Chompret A, Helbling-Leclerc A, Stoppa-Lyonnet D, Belotti M, Nogues C, Bonaiti-Pellie C, Sex ratio among the offspring of BRCA mutation carriersJAMA2004; 292: 687\u2013688", "journal-title": "JAMA"}, {"key": "9097_CR7", "first-page": "e103", "volume": "41", "author": "K Kotar", "year": "2004", "unstructured": "Kotar K, Brunet JS, Moller P, Hugel L, Warner E, McLaughlin J, Wong N, Narod SA, Foulkes WD., Ratio of female to male offspring of women tested for BRCA1 and BRCA2 mutationsJ Med Genet 2004; 41:e103", "journal-title": "J Med Genet"}, {"key": "9097_CR8", "first-page": "273", "volume": "92", "author": "J Balmana", "year": "2005", "unstructured": "Balmana J, Diez O, Campos B, Majewski M, Sanz J, Alonso C, Baiget M, Garber JE, Sex ratio distortion in offspring of families with BRCA1 or BRCA2 mutant alleles: an ascertainment bias phenomenon? Breast Cancer Res Treat 2005;92:273\u2013277", "journal-title": "Breast Cancer Res Treat"}, {"key": "9097_CR9", "first-page": "73", "volume": "4", "author": "G Chenevix-Trench", "year": "2005", "unstructured": "Chenevix-Trench G, Sinilnikova OM, Suthers G, Pandeya N, Mazoyer S, Sambrook JF, Goldup S, Goldgar D, Lynch HT, Lenoir GM, Cheetham G, kConFab. Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriersFam Cancer 2005;4:73\u201375", "journal-title": "Fam Cancer"}, {"key": "9097_CR10", "first-page": "166", "volume": "113", "author": "M la Hoya De", "year": "2005", "unstructured": "De la Hoya M, Meijers-Heijboer H, Fernandez JM, Diez O, Osorio A, Alonso C, Van Leeuwen I, Diaz-Rubio E, Cornelisse C, Benitez J, Devilee P, Caldes T, Mutant BRCA1 alleles transmission: different approaches and different biasesInt J Cancer 2005; 113:166\u2013167", "journal-title": "Int J Cancer"}, {"key": "9097_CR11", "first-page": "683", "volume": "110", "author": "B Gorski", "year": "2004", "unstructured": "Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J, A high proportion of founder BRCA1 mutations in Polish breast cancer familiesInt J Cancer 2004; 110:683\u2013686", "journal-title": "Int J Cancer"}, {"key": "9097_CR12", "unstructured": "Polish Main Statistics Office. Available at: http://www.gus.pl"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-005-9097-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2013, 3, 29]], "date-time": "2013-03-29T17:54:36Z", "timestamp": 1364579676000}, "score": 17.564919, "issued": {"date-parts": [[2005, 12, 1]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2006, 5]]}, "issue": "1"}, "alternative-id": ["9097"], "URL": "http://dx.doi.org/10.1007/s10549-005-9097-4", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T03:40:12Z", "timestamp": 1547178012555}, "reference-count": 16, "publisher": "Springer Nature", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2006, 11, 7]]}, "DOI": "10.1007/s10549-006-9261-5", "type": "journal-article", "created": {"date-parts": [[2006, 6, 28]], "date-time": "2006-06-28T10:49:28Z", "timestamp": 1151491768000}, "page": "239-245", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Direct-to-patient BRCA1 testing: the Twoj Styl experience"], "prefix": "10.1007", "volume": "100", "author": [{"given": "Jacek", "family": "Gronwald", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Tadeusz", "family": "D\u0119bniak", "sequence": "additional", "affiliation": []}, {"given": "Kelly", "family": "Metcalfe", "sequence": "additional", "affiliation": []}, {"given": "Steven A.", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 6, 29]]}, "reference": [{"issue": "23", "key": "9261_CR1", "doi-asserted-by": "crossref", "first-page": "3136", "DOI": "10.1001/jama.287.23.3136", "volume": "287", "author": "LM Schwartz", "year": "2002", "unstructured": "Schwartz LM, Woloshin S (2002) News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. JAMA 287(23):3136\u20133142", "journal-title": "JAMA"}, {"issue": "1", "key": "9261_CR2", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1002/1096-8628(20010101)98:1<15::AID-AJMG1014>3.0.CO;2-0", "volume": "98", "author": "L Lodder", "year": "2001", "unstructured": "Lodder L, Frets PG, Trijsburg RW, et al (2001) Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 98(1):15\u201324", "journal-title": "Am J Med Genet"}, {"issue": "2", "key": "9261_CR3", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1136/jmg.38.2.139", "volume": "38", "author": "P Hopwood", "year": "2001", "unstructured": "Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A (2001) Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 38(2):139", "journal-title": "J Med Genet"}, {"issue": "9", "key": "9261_CR4", "doi-asserted-by": "crossref", "first-page": "731", "DOI": "10.1136/jmg.35.9.731", "volume": "35", "author": "M Watson", "year": "1998", "unstructured": "Watson M, Duvivier V, Wade Walsh M, et al (1998) Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 35(9):731\u2013738", "journal-title": "J Med Genet"}, {"issue": "10", "key": "9261_CR5", "doi-asserted-by": "crossref", "first-page": "720", "DOI": "10.1093/jnci/87.10.720", "volume": "87", "author": "WC Black", "year": "1995", "unstructured": "Black WC, Nease RF, Tosteson AN (1995) Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87(10):720\u2013731", "journal-title": "J Natl Cancer Inst"}, {"issue": "3", "key": "9261_CR6", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1002/(SICI)1097-0142(19970801)80:3<413::AID-CNCR9>3.0.CO;2-S", "volume": "80", "author": "NC Dolan", "year": "1997", "unstructured": "Dolan NC, Lee AM, McDermott MM (1997) Age-related differences in breast carcinoma knowledge, beliefs, and perceived risk among women visiting an academic general medicine practice. Cancer 80(3):413\u2013420", "journal-title": "Cancer"}, {"issue": "6", "key": "9261_CR7", "first-page": "392", "volume": "88", "author": "N Hebert-Croteau", "year": "1997", "unstructured": "Hebert-Croteau N, Goggin P, Kishchuk N (1997) Estimation of breast cancer risk by women aged 40 and over: a population-based study. Can J Public Health 88(6):392\u2013396", "journal-title": "Can J Public Health"}, {"key": "9261_CR8", "doi-asserted-by": "crossref", "first-page": "866", "DOI": "10.1136/jmg.37.11.866", "volume": "37", "author": "KA Metcalfe", "year": "2000", "unstructured": "Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA (2000) An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet 37:866\u2013874", "journal-title": "J Med Genet"}, {"issue": "1", "key": "9261_CR9", "first-page": "93", "volume": "25", "author": "J Menkiszak", "year": "2004", "unstructured": "Menkiszak J, Rzepka-Gorska I, Gorski B, et al (2004) Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland. Eur J Gynaecol Oncol 25(1): 93\u201395", "journal-title": "Eur J Gynaecol Oncol"}, {"issue": "5", "key": "9261_CR10", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1002/ijc.20162", "volume": "110", "author": "B Gorski", "year": "2004", "unstructured": "Gorski B, Jakubowska A, Huzarski T, et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110(5):683\u2013686", "journal-title": "Int J Cancer"}, {"key": "9261_CR11", "doi-asserted-by": "crossref", "first-page": "1494", "DOI": "10.1086/316907", "volume": "67", "author": "A Liede", "year": "2000", "unstructured": "Liede A, Metcalfe K, Hanna D, et al (2000) Evaluation of the needs of male carriers of mutations in either BRCA1 or BRCA2 who are undergoing genetic counseling. Am J Human Genet 67:1494\u20131504", "journal-title": "Am J Human Genet"}, {"key": "9261_CR12", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1034/j.1399-0004.2002.620607.x", "volume": "62", "author": "KA Metcalfe", "year": "2002", "unstructured": "Metcalfe KA, Liede A, Trinkaus M, Hanna D, Narod SA (2002) Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clin Genet 62:464\u2013469", "journal-title": "Clin Genet"}, {"issue": "24", "key": "9261_CR13", "doi-asserted-by": "crossref", "first-page": "1885", "DOI": "10.1001/jama.1996.03530480027036", "volume": "275", "author": "C Lerman", "year": "1996", "unstructured": "Lerman C, Narod S, Schulman K, et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 275(24):1885\u20131892", "journal-title": "JAMA"}, {"key": "9261_CR14", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1002/pon.726", "volume": "13", "author": "KA Metcalfe", "year": "2004", "unstructured": "Metcalfe KA, Esplen MJ, Goel V, Narod S (2004) Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology 13:14\u201325", "journal-title": "Psychooncology"}, {"key": "9261_CR15", "unstructured": "Lubinski J, Gorski B, Huzarski T, et al (2006) BRCA1- positive breast cancers in young women from Poland. Breast Cancer Res Treat Mar 16; [Epub ahead of print]", "DOI": "10.1007/s10549-006-9182-3", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "9261_CR16", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1097/01.GIM.0000156526.16967.7A", "volume": "7", "author": "J Mouchawar", "year": "2005", "unstructured": "Mouchawar J, Hensley-Alford S, Laurion S, et al (2005) Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med 7(3):191\u2013197", "journal-title": "Genet Med"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-006-9261-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T03:01:34Z", "timestamp": 1547175694000}, "score": 17.564919, "issued": {"date-parts": [[2006, 6, 29]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2006, 11, 7]]}, "issue": "3"}, "alternative-id": ["9261"], "URL": "http://dx.doi.org/10.1007/s10549-006-9261-5", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T17:18:31Z", "timestamp": 1525540711397}, "reference-count": 1, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 22492, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1954, 2]]}, "DOI": "10.1111/j.1945-5100.1954.tb01325.x", "type": "journal-article", "created": {"date-parts": [[2012, 9, 3]], "date-time": "2012-09-03T12:18:10Z", "timestamp": 1346674690000}, "page": "142-149", "source": "Crossref", "is-referenced-by-count": 0, "title": ["GRAPHIC INVESTIGATION OF A FIREBALL TRAJECTORY*"], "prefix": "10.1111", "volume": "1", "author": [{"given": "RICHARD G.", "family": "HUZARSKI", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 9, 3]]}, "reference": [{"issue": "3", "key": "10.1111/j.1945-5100.1954.tb01325.x-BIB1|cit1", "first-page": "78", "article-title": "Recent and Future Developments in Meteoritics", "volume": "1", "author": "Leonard", "year": "1953", "journal-title": "Mrtcs."}], "container-title": ["Meteoritics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1945-5100.1954.tb01325.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 4, 14]], "date-time": "2017-04-14T23:01:38Z", "timestamp": 1492210898000}, "score": 16.053009, "issued": {"date-parts": [[1954, 2]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1954, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1111/j.1945-5100.1954.tb01325.x", "relation": {"cites": []}, "ISSN": ["0026-1114"], "issn-type": [{"value": "0026-1114", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T13:42:40Z", "timestamp": 1525700560472}, "reference-count": 0, "publisher": "Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CLR"], "DOI": "10.12775/clr.2016.011", "type": "journal-article", "created": {"date-parts": [[2017, 6, 8]], "date-time": "2017-06-08T07:10:36Z", "timestamp": 1496905836000}, "page": "115", "source": "Crossref", "is-referenced-by-count": 0, "title": ["MARSHAL OF THE SEJM AS A CONSTITUTIONAL BODY OF THE STATE"], "prefix": "10.12775", "volume": "22", "author": [{"given": "Micha\u0142", "family": "Huzarski", "sequence": "first", "affiliation": []}, {"given": "Micha\u0142", "family": "Pyrz", "sequence": "additional", "affiliation": []}], "member": "5093", "published-online": {"date-parts": [[2017, 5, 23]]}, "container-title": ["Comparative Law Review"], "link": [{"URL": "http://apcz.umk.pl/czasopisma/index.php/CLR/article/viewFile/13473/12141", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 8]], "date-time": "2017-06-08T07:10:57Z", "timestamp": 1496905857000}, "score": 16.053009, "issued": {"date-parts": [[2017, 5, 23]]}, "references-count": 0, "URL": "http://dx.doi.org/10.12775/clr.2016.011", "ISSN": ["0866-9449"], "issn-type": [{"value": "0866-9449", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T00:47:21Z", "timestamp": 1525308441205}, "reference-count": 0, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hered Cancer Clin Pract", "Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1186/1897-4287-4-1-57", "type": "journal-article", "created": {"date-parts": [[2010, 3, 11]], "date-time": "2010-03-11T19:15:35Z", "timestamp": 1268334935000}, "page": "57", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Population Screening of CHEK2 Mutations in Poland"], "prefix": "10.1186", "volume": "4", "author": [{"given": "Cezary", "family": "Cybulski", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jowita", "family": "Huzarska", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Oleg", "family": "Oszurek", "sequence": "additional", "affiliation": []}, {"given": "Jolanta", "family": "Grajczyk", "sequence": "additional", "affiliation": []}, {"given": "Ligia", "family": "Sikora", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:13:11Z", "timestamp": 1463418791000}, "score": 15.2579365, "issued": {"date-parts": [[2006]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006]]}, "issue": "1"}, "alternative-id": ["1897-4287-4-1-57"], "URL": "http://dx.doi.org/10.1186/1897-4287-4-1-57", "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T16:50:34Z", "timestamp": 1525452634440}, "reference-count": 8, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2005, 3]]}, "DOI": "10.1007/s10549-004-3778-2", "type": "journal-article", "created": {"date-parts": [[2005, 3, 30]], "date-time": "2005-03-30T18:45:42Z", "timestamp": 1112208342000}, "page": "187-189", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Pathology of breast cancer in women with constitutional CHEK2 mutations"], "prefix": "10.1007", "volume": "90", "author": [{"given": "Tomasz", "family": "Huzarski", "sequence": "first", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Wenancjusz", "family": "Domaga\u0142a", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Marek", "family": "Szwiec", "sequence": "additional", "affiliation": []}, {"given": "Stanis\u0142aw", "family": "Woyke", "sequence": "additional", "affiliation": []}, {"given": "Steven A", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "3778_CR1", "author": "CHEK2 Breast Cancer Consortium", "volume": "31", "first-page": "55", "year": "2002", "journal-title": "Nat Genet"}, {"key": "3778_CR2", "author": "CHEK2 Breast Cancer Case-Control Consortium", "volume": "74", "first-page": "1175", "year": "2004", "journal-title": "Am J Hum Genet"}, {"key": "3778_CR3", "unstructured": "Cybulski C, G\u00f3rski B, Huzarski T, Masoj\u0107 B, Mierzejewski M, D\u0119bniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Z\u0142owocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Szyma\u0144ska A, Szyma\u0144ska J, M\u0119drek K, Kurzawski G, Suchy J, Witek A, Narod SA, Lubi\u0144ski J: CHEK2 is a multi-organ cancer susceptibility gene. Am J Hum Genet (accepted)."}, {"issue": "8", "key": "3778_CR4", "first-page": "2677", "volume": "64", "author": "C Cybulski", "year": "2004", "journal-title": "Cancer Res"}, {"key": "3778_CR5", "author": "O Kilpivaara", "volume": "111", "first-page": "543", "year": "2004", "journal-title": "Int J Cancer"}, {"key": "3778_CR6", "first-page": "338", "year": "2003", "volume-title": "Pathology and Genetics; Tumours of the Breast and Female Genital Organs"}, {"key": "3778_CR7", "unstructured": "Huzarski T, Lener M, Domaga\u0142a W, Gronwald J, Byrski T, Kurzawski G, Suchy J, Chosia M, Woyton J, Ucinski M, Narod SA, Lubi\u0144ski J: The 3020insC Allele of NOD2 Predisposes to Early-Onset Breast Cancer. Breast Cancer Res Treatment (in press)."}, {"key": "3778_CR8", "author": "M Schutte", "volume": "72", "first-page": "1023", "year": "2003", "journal-title": "Am J Hum Genet"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-004-3778-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2013, 3, 29]], "date-time": "2013-03-29T17:51:37Z", "timestamp": 1364579497000}, "score": 15.2579365, "issued": {"date-parts": [[2005, 3]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2005, 3]]}, "issue": "2"}, "alternative-id": ["3778"], "URL": "http://dx.doi.org/10.1007/s10549-004-3778-2", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T04:49:15Z", "timestamp": 1525409355316}, "reference-count": 12, "publisher": "Springer Nature", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1007/s10549-008-9892-9", "type": "journal-article", "created": {"date-parts": [[2008, 1, 17]], "date-time": "2008-01-17T14:49:49Z", "timestamp": 1200581389000}, "page": "581-584", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Early radiation exposures and BRCA1-associated breast cancer in young women from Poland"], "prefix": "10.1007", "volume": "112", "author": [{"given": "Jacek", "family": "Gronwald", "sequence": "first", "affiliation": []}, {"given": "Anouk", "family": "Pijpe", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Ma\u0142gorzata", "family": "Stawicka", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Flora", "family": "van Leeuwen", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}, {"given": "Steven A.", "family": "Narod", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 1, 18]]}, "reference": [{"key": "9892_CR1", "first-page": "220", "volume": "158", "author": "DL Preston", "year": "2002", "unstructured": "Preston DL, Mattsson A, Holmberg E et\u00a0al (2002) Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158:220\u2013235", "journal-title": "Radiat Res"}, {"key": "9892_CR2", "first-page": "971", "volume": "95", "author": "FE Leeuwen van", "year": "2003", "unstructured": "van Leeuwen FE, Klokman WJ, Stovall M et\u00a0al (2003) Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease. J Natl Cancer Inst 95:971\u2013980", "journal-title": "J Natl Cancer Inst"}, {"key": "9892_CR3", "first-page": "707", "volume": "160", "author": "CE Land", "year": "2003", "unstructured": "Land CE, Tokunaga M, Koyama K et\u00a0al (2003) Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950\u20131990. Radiat Res 160:707\u2013717", "journal-title": "Radiat Res"}, {"key": "9892_CR4", "first-page": "1307", "volume": "81", "author": "DA Hoffman", "year": "1989", "unstructured": "Hoffman DA, Lonstein JE, Morin MM et\u00a0al (1989) Breast cancer in women with scoliosis exposed to multiple diagnostic X rays. J Natl Cancer Inst 81:1307\u20131312", "journal-title": "J Natl Cancer Inst"}, {"key": "9892_CR5", "first-page": "171", "volume": "108", "author": "AR Venkitaraman", "year": "2002", "unstructured": "Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171\u2013182", "journal-title": "Cell"}, {"key": "9892_CR6", "first-page": "201", "volume": "404", "author": "JS Lee", "year": "2000", "unstructured": "Lee JS, Collins KM, Brown AL et\u00a0al (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404:201\u2013204", "journal-title": "Nature"}, {"key": "9892_CR7", "first-page": "477", "volume": "405", "author": "X Wu", "year": "2000", "unstructured": "Wu X, Ranganathan V, Weisman DS et\u00a0al (2000) ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405:477\u2013482", "journal-title": "Nature"}, {"key": "9892_CR8", "unstructured": "Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE); Gene Etude Prospective Sein Ovaire (GENEPSO); Gen en Omgeving studie van de werkgroep Hereditiair Borstkanker Onderzoek Nederland (GEO-HEBON) et\u00a0al (2006) Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators\u2019 Group. J Clin Oncol 24:3361\u20133366"}, {"key": "9892_CR9", "first-page": "71", "volume": "99", "author": "J Lubinski", "year": "2006", "unstructured": "Lubinski J, Gorski B, Huzarski T et\u00a0al (2006) BRCA1-positive breast cancers in young women from Poland. Breast Cancer Res Treat 99:71\u201376", "journal-title": "Breast Cancer Res Treat"}, {"issue": "5", "key": "9892_CR10", "first-page": "683", "volume": "110", "author": "B G\u00f3rski", "year": "2004", "unstructured": "G\u00f3rski B, Jakubowska A, Huzarski T et\u00a0al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110(5):683\u2013686", "journal-title": "Int J Cancer"}, {"key": "9892_CR11", "first-page": "402", "volume": "7", "author": "SA Narod", "year": "2006", "unstructured": "Narod SA, Lubinski J, Ghadirian P et\u00a0al (2006) Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 7:402\u2013406", "journal-title": "Lancet Oncol"}, {"key": "9892_CR12", "first-page": "2311", "volume": "15", "author": "D Goldfrank", "year": "2006", "unstructured": "Goldfrank D, Chuai S, Bernstein JL et\u00a0al (2006) Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev 15:2311\u20132313", "journal-title": "Cancer Epidemiol Biomarkers Prev"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10549-008-9892-9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2014, 9, 4]], "date-time": "2014-09-04T00:25:09Z", "timestamp": 1409790309000}, "score": 15.2579365, "issued": {"date-parts": [[2008, 1, 18]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2008, 12]]}, "issue": "3"}, "alternative-id": ["9892"], "URL": "http://dx.doi.org/10.1007/s10549-008-9892-9", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 8, 27]], "date-time": "2018-08-27T12:02:33Z", "timestamp": 1535371353647}, "reference-count": 24, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2006, 1]]}, "DOI": "10.1007/s10549-005-9051-5", "type": "journal-article", "created": {"date-parts": [[2005, 10, 31]], "date-time": "2005-10-31T13:28:59Z", "timestamp": 1130765339000}, "page": "105-109", "source": "Crossref", "is-referenced-by-count": 44, "title": ["Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland"], "prefix": "10.1007", "volume": "95", "author": [{"given": "Jacek", "family": "Gronwald", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Ping", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Tulman", "sequence": "additional", "affiliation": []}, {"given": "Steven A.", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 10, 27]]}, "reference": [{"key": "9051_CR1", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1002/ajmg.1320560305", "volume": "56", "author": "DF Easton", "year": "1995", "unstructured": "Easton DF, Ford D, Bishop DT, Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium Am J Hum Genet 56: 265\u2013271, 1995", "journal-title": "Am J Hum Genet"}, {"key": "9051_CR2", "first-page": "602", "volume": "42", "author": "AC Antoniou", "year": "2005", "unstructured": "Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF, Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations a combined analysis of 22 population based studies. J Med Genet 42: 602\u2013603 2005", "journal-title": "J Med Genet"}, {"key": "9051_CR3", "first-page": "113", "volume": "2", "author": "SA Narod", "year": "2002", "unstructured": "Narod SA, Modifiers of risk of hereditary breast and ovarian cancer Nat Rev Cancer 2: 113\u20131232002", "journal-title": "Nat Rev Cancer"}, {"key": "9051_CR4", "first-page": "1117", "volume": "72", "author": "A Antoniou", "year": "2003", "unstructured": "Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72: 1117\u20131130, 2003", "journal-title": "Am J Hum Genet"}, {"key": "9051_CR5", "first-page": "643", "volume": "24", "author": "MC King", "year": "2003", "unstructured": "King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 24: 643\u2013646, 2003", "journal-title": "Science"}, {"key": "9051_CR6", "first-page": "1259", "volume": "66", "author": "R Moslehi", "year": "2000", "unstructured": "Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA, BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66: 1259\u20131272, 2000", "journal-title": "Am J Hum Genet"}, {"key": "9051_CR7", "first-page": "1241", "volume": "91", "author": "E Warner", "year": "1999", "unstructured": "Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 91: 1241\u20131247, 1999", "journal-title": "J Natl Cancer Inst"}, {"key": "9051_CR8", "first-page": "2328", "volume": "22", "author": "K Metcalfe", "year": "2004", "unstructured": "Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA, Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 22: 2328\u20132335, 2004", "journal-title": "J Clin Oncol"}, {"key": "9051_CR9", "first-page": "683", "volume": "110", "author": "B Gorski", "year": "2004", "unstructured": "Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J, A high proportion of founder BRCA1 mutations in polish breast cancer families Int J Cancer 110: 683\u2013686, 2004", "journal-title": "Int J Cancer"}, {"key": "9051_CR10", "unstructured": "Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA, and the Hereditary Breast Cancer Clinical Study Group. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer in press"}, {"key": "9051_CR11", "first-page": "1876", "volume": "356", "author": "SA Narod", "year": "2000", "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H, Hereditary Breast Cancer Clinical Study Group. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case\u2013control study. Hereditary Breast Cancer Clinical Study Group Lancet 356: 1876\u20131881, 2000", "journal-title": "Lancet"}, {"key": "9051_CR12", "unstructured": "Eisen A, Lubinski J, Klijn J, Moller P, Lynch H, Offit K, Weber B, Rebbeck T, Neuhausen S, Ghadirian P, Foulkes W, Gershoni-Baruch R, Friedman E, Rennert G, Isaacs C, Kim-Sing C, Ainsworth P, Couch F, Garber J, Daly M, Rosen B, Olopade O, Karlan B, Tung N, Saal H, Weitzel J, Eng C, Sun P, Narod SA: Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case\u2013control study. J Clin Oncol (in press)"}, {"key": "9051_CR13", "first-page": "1475", "volume": "91", "author": "TR Rebbeck", "year": "1999", "unstructured": "Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL, Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst 91: 1475\u20131479, 1999", "journal-title": "J Natl Cancer Inst"}, {"key": "9051_CR14", "first-page": "2029", "volume": "10", "author": "WD Foulkes", "year": "2004", "unstructured": "Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Begin LR, Narod SA, Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type Clin Cancer Res 10: 2029\u20132034, 2004", "journal-title": "Clin Cancer Res"}, {"key": "9051_CR15", "unstructured": "Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA: Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005 Jun 28; [Epub ahead of print]"}, {"key": "9051_CR16", "first-page": "1706", "volume": "345", "author": "SA Narod", "year": "2001", "unstructured": "Narod SA, Sun P, Risch HA, Hereditary Ovarian Cancer Clinical Study Group. Ovarian cancer, oral contraceptives, and BRCA mutationsN Engl J Med 345: 1706\u20131707, 2001", "journal-title": "N Engl J Med"}, {"key": "9051_CR17", "first-page": "1010", "volume": "95", "author": "JL Hopper", "year": "2003", "unstructured": "Hopper JL, Baron JA, Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 95: 1010\u20131011, 2003", "journal-title": "J Natl Cancer Inst"}, {"key": "9051_CR18", "first-page": "1911", "volume": "91", "author": "AS Whittemore", "year": "2004", "unstructured": "Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS, Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations Br J Cancer 91: 1911\u20131915, 2004", "journal-title": "Br J Cancer"}, {"key": "9051_CR19", "first-page": "36", "volume": "15", "author": "JL Kelsey", "year": "1993", "unstructured": "Kelsey JL, Gammon MD, John EM, Reproductive factors and breast cancer Epidemiol Rev 15: 36\u201347, 1993", "journal-title": "Epidemiol Rev"}, {"key": "9051_CR20", "first-page": "667", "volume": "16", "author": "J Kotsopoulos", "year": "2005", "unstructured": "Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen S, Ghadirian P, Isaacs C, Horsman D, Weber B, Foulkes WD, Ainsworth P, Daly M, Olopade O, Tung N, Saal H, Eisen A, Sun P, Narod SA, Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Cancer Causes Control 16: 667\u2013674, 2005", "journal-title": "Cancer Causes Control"}, {"key": "9051_CR21", "first-page": "302", "volume": "92", "author": "L Lipworth", "year": "2000", "unstructured": "Lipworth L, Bailey LR, Trichopoulos D, History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature J Natl Cancer Inst 92: 302\u2013312, 2000", "journal-title": "J Natl Cancer Inst"}, {"key": "9051_CR22", "first-page": "1094", "volume": "96", "author": "H Jernstrom", "year": "2004", "unstructured": "Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA, Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 96: 1094\u20131098, 2004", "journal-title": "J Natl Cancer Inst"}, {"key": "9051_CR23", "first-page": "413", "volume": "110", "author": "P Ghadirian", "year": "2004", "unstructured": "Ghadirian P, Lubinski J, Lynch H, Neuhausen SL, Weber B, Isaacs C, Baruch RG, Randall S, Ainsworth P, Friedman E, Horsman D, Tonin P, Foulkes WD, Tung N, Sun P, Narod SA, Smoking and the risk of breast cancer among carriers of BRCA mutations Int J Cancer 110: 413\u2013416, 2004", "journal-title": "Int J Cancer"}, {"key": "9051_CR24", "unstructured": "Nkondjock A, Ghadirian P, Lubinski J, Lynch H, Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N, Eisen A, Friedman E, Eng C, Kotsopoulos J, Sun P, Narod SA: Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 2005 Jul 19 [Epub ahead of print]"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-005-9051-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 17]], "date-time": "2017-06-17T00:28:58Z", "timestamp": 1497659338000}, "score": 15.2579365, "issued": {"date-parts": [[2005, 10, 27]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2006, 1]]}, "issue": "2"}, "alternative-id": ["9051"], "URL": "http://dx.doi.org/10.1007/s10549-005-9051-5", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 12, 21]], "date-time": "2018-12-21T03:02:42Z", "timestamp": 1545361362696}, "reference-count": 41, "publisher": "Wiley", "issue": "9", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2130, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Cancer"], "published-print": {"date-parts": [[2009, 11, 1]]}, "DOI": "10.1002/ijc.24600", "type": "journal-article", "created": {"date-parts": [[2009, 5, 28]], "date-time": "2009-05-28T19:53:19Z", "timestamp": 1243540399000}, "page": "2209-2213", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Elevated level of 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine in leukocytes ofBRCA1mutation carriers compared to healthy controls"], "prefix": "10.1002", "volume": "125", "author": [{"given": "Tomasz", "family": "Dziaman", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Daniel", "family": "Gackowski", "sequence": "additional", "affiliation": []}, {"given": "Rafal", "family": "Rozalski", "sequence": "additional", "affiliation": []}, {"given": "Agnieszka", "family": "Siomek", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Szpila", "sequence": "additional", "affiliation": []}, {"given": "Jolanta", "family": "Guz", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}, {"given": "Ryszard", "family": "Olinski", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/ijc.24600-BIB1", "first-page": "676", "article-title": "Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium", "volume": "62", "author": "Ford", "year": "1998", "journal-title": "Am J Hum Genet"}, {"key": "10.1002/ijc.24600-BIB2", "first-page": "425", "article-title": "Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage", "volume": "90", "author": "Scully", "year": "1997", "journal-title": "Cell"}, {"key": "10.1002/ijc.24600-BIB3", "first-page": "265", "article-title": "Association of BRCA1 with Rad51 in mitotic and meiotic cells", "volume": "88", "author": "Scully", "year": "1997", "journal-title": "Cell"}, {"key": "10.1002/ijc.24600-BIB4", "first-page": "18808", "article-title": "BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair", "volume": "274", "author": "Abbott", "year": "1999", "journal-title": "J Biol Chem"}, {"key": "10.1002/ijc.24600-BIB5", "first-page": "3115", "article-title": "A targeted disruption of the murine BRCA1 gene causes gamma-irradiation hypersensitivity and genetic instability", "volume": "17", "author": "Shen", "year": "1998", "journal-title": "Oncogene"}, {"key": "10.1002/ijc.24600-BIB6", "first-page": "2488", "article-title": "Lymphoblasts of women with BRCA1 mutations are deficient incellular repair of 8,5\u2032-Cyclopurine-2\u2032-deoxynucleosides and 8-hydroxy-2\u2032-deoxyguanosine", "volume": "46", "author": "Rodriguez", "year": "2007", "journal-title": "Biochemistry"}, {"key": "10.1002/ijc.24600-BIB7", "first-page": "30", "article-title": "Does measurement of oxidative damage to DNA have clinical significance?", "volume": "365", "author": "Cooke", "year": "2006", "journal-title": "Clin Chim Acta"}, {"key": "10.1002/ijc.24600-BIB8", "first-page": "166", "article-title": "8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G--T and A--C substitutions", "volume": "267", "author": "Cheng", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "10.1002/ijc.24600-BIB9", "first-page": "1447", "article-title": "The role of 8-hydroxyguanine in carcinogenesis", "volume": "11", "author": "Floyd", "year": "1990", "journal-title": "Carcinogenesis"}, {"key": "10.1002/ijc.24600-BIB10", "first-page": "691", "article-title": "Levels of 5-hydroxymethyl-2\u2032-deoxyuridine in DNA from blood as a marker of breast cancer", "volume": "77", "author": "Djuric", "year": "1996", "journal-title": "Cancer"}, {"key": "10.1002/ijc.24600-BIB11", "first-page": "147", "article-title": "Levels of 5-hydroxymethyl-2\u2032-deoxyuridine in DNA from blood of women scheduled for breast biopsy", "volume": "10", "author": "Djuric", "year": "2001", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "10.1002/ijc.24600-BIB12", "first-page": "214", "article-title": "Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer", "volume": "31", "author": "Li", "year": "2001", "journal-title": "Mol Carcinog"}, {"key": "10.1002/ijc.24600-BIB13", "first-page": "1209", "article-title": "Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis", "volume": "32A", "author": "Musarrat", "year": "1996", "journal-title": "Eur J Cancer"}, {"key": "10.1002/ijc.24600-BIB14", "first-page": "1011", "article-title": "Urinary measurement of 8-OxodG, 8-OxoGua, and 5HMUra: a noninvasive assessment of oxidative damage to DNA", "volume": "8", "author": "Olinski", "year": "2006", "journal-title": "Antioxid Redox Signal"}, {"key": "10.1002/ijc.24600-BIB15", "first-page": "1072", "article-title": "The level of 8-hydroxyguanine, a possible repair product of oxidative DNA damage, is higher in urine of cancer patients than in control subjects", "volume": "11", "author": "Rozalski", "year": "2002", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "10.1002/ijc.24600-BIB16", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1016/j.mrfmmm.2003.07.005", "article-title": "Oxidative DNA damage in cancer patients: a cause or a consequence of the disease development?", "volume": "531", "author": "Olinski", "year": "2003", "journal-title": "Mutat Res"}, {"key": "10.1002/ijc.24600-BIB17", "first-page": "1963", "article-title": "Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer", "volume": "66", "author": "G\u00f3rski", "year": "2000", "journal-title": "Am J Hum Genet"}, {"key": "10.1002/ijc.24600-BIB18", "first-page": "143", "article-title": "Higher leukocyte 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine and lower plasma ascorbate in aging humans?", "volume": "9", "author": "Siomek", "year": "2007", "journal-title": "Antioxid Redox Signal"}, {"key": "10.1002/ijc.24600-BIB19", "first-page": "9", "article-title": "Determination of new types of DNA lesions in human sperm", "volume": "16", "author": "Badouard", "year": "2008", "journal-title": "Zygote"}, {"key": "10.1002/ijc.24600-BIB20", "first-page": "695", "article-title": "Diet modification affects DNA oxidative damage in healthy humans", "volume": "26", "author": "Chen", "year": "1999", "journal-title": "Free Radic Biol Med"}, {"key": "10.1002/ijc.24600-BIB21", "first-page": "13", "article-title": "Levels of 8-hydroxydeoxyguanosine as a marker of DNA damage in human leukocytes", "volume": "28", "author": "Lodovici", "year": "2000", "journal-title": "Free Radic Biol Med"}, {"key": "10.1002/ijc.24600-BIB22", "first-page": "153", "article-title": "Oxidative DNA damage and antioxidant vitamin level: comparison among lung cancer patients, healthy smokers and nonsmokers", "volume": "114", "author": "Gackowski", "year": "2005", "journal-title": "Int J Cancer"}, {"key": "10.1002/ijc.24600-BIB23", "first-page": "395", "article-title": "Persistent oxidative stress in colorectal carcinoma patients", "volume": "101", "author": "Gackowski", "year": "2002", "journal-title": "Int J Cancer"}, {"key": "10.1002/ijc.24600-BIB24", "first-page": "4756", "article-title": "Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients", "volume": "61", "author": "Schmielau", "year": "2001", "journal-title": "Cancer Res"}, {"key": "10.1002/ijc.24600-BIB25", "author": "Franks", "year": "1997", "volume-title": "Introduction to the cellular and molecular biology of cancer"}, {"key": "10.1002/ijc.24600-BIB26", "first-page": "15488", "article-title": "Suppression of antioxidative enzyme expression by transforming growth factor-beta 1 in rat hepatocytes", "volume": "269", "author": "Kayanoki", "year": "1994", "journal-title": "J Biol Chem"}, {"key": "10.1002/ijc.24600-BIB27", "first-page": "1079", "article-title": "Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells", "volume": "126", "author": "Ohba", "year": "1994", "journal-title": "J Cell Biol"}, {"key": "10.1002/ijc.24600-BIB28", "first-page": "625", "article-title": "Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentration", "volume": "99", "author": "Peddie", "year": "1997", "journal-title": "Br J Haematol"}, {"key": "10.1002/ijc.24600-BIB29", "first-page": "794", "article-title": "Production of large amounts of hydrogen peroxide by human tumor cells", "volume": "51", "author": "Szatrowski", "year": "1991", "journal-title": "Cancer Res"}, {"key": "10.1002/ijc.24600-BIB30", "author": "De Vita", "year": "2001", "volume-title": "Cancer principles & practice of oncology"}, {"key": "10.1002/ijc.24600-BIB31", "first-page": "1269", "article-title": "Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes", "volume": "53", "author": "Dizdaroglu", "year": "1993", "journal-title": "Cancer Res"}, {"key": "10.1002/ijc.24600-BIB32", "first-page": "754", "article-title": "DNA repair proficiency: potential susceptiblity factor for breast cancer", "volume": "88", "author": "Helzlsouer", "year": "1996", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/ijc.24600-BIB33", "first-page": "77", "article-title": "Brcal required for T cell lineage development but not TCR loci rearrangement", "volume": "1", "author": "Mak", "year": "2000", "journal-title": "Nat Immunol"}, {"key": "10.1002/ijc.24600-BIB34", "first-page": "1108", "article-title": "Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia", "volume": "95", "author": "Scardocci", "year": "2006", "journal-title": "Br J Cancer"}, {"key": "10.1002/ijc.24600-BIB35", "first-page": "1449", "article-title": "Urinary excretion of DNA repair products correlates with metabolic rates as well as with maximum life spans of different mammalian species", "volume": "37", "author": "Foksinski", "year": "2004", "journal-title": "Free Radic Biol Med"}, {"key": "10.1002/ijc.24600-BIB36", "first-page": "171", "article-title": "Cancer susceptibility and the functions of BRCA1 and BRCA2", "volume": "108", "author": "Venkitaraman", "year": "2002", "journal-title": "Cell"}, {"key": "10.1002/ijc.24600-BIB37", "first-page": "3882", "article-title": "Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol", "volume": "51", "author": "Roy", "year": "1991", "journal-title": "Cancer Res"}, {"key": "10.1002/ijc.24600-BIB38", "first-page": "2571", "article-title": "Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones", "volume": "16", "author": "Han", "year": "1995", "journal-title": "Carcinogenesis"}, {"key": "10.1002/ijc.24600-BIB39", "first-page": "225", "article-title": "Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility", "volume": "39", "author": "de Jong", "year": "2002", "journal-title": "J Med Genet"}, {"key": "10.1002/ijc.24600-BIB40", "first-page": "384", "article-title": "Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients", "volume": "97", "author": "Speina", "year": "2005", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/ijc.24600-BIB41", "first-page": "174", "article-title": "Effects of basal level of antioxidants on oxidative DNA damage in humans", "volume": "46", "author": "Foksinski", "year": "2007", "journal-title": "Eur J Nutr"}], "container-title": ["International Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.24600", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 18]], "date-time": "2017-06-18T20:23:26Z", "timestamp": 1497817406000}, "score": 15.2579365, "issued": {"date-parts": [[2009, 11, 1]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2009, 11, 1]]}, "issue": "9"}, "URL": "http://dx.doi.org/10.1002/ijc.24600", "relation": {"cites": []}, "ISSN": ["0020-7136", "1097-0215"], "issn-type": [{"value": "0020-7136", "type": "print"}, {"value": "1097-0215", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T13:40:57Z", "timestamp": 1547386857756}, "reference-count": 31, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2007, 6, 20]]}, "DOI": "10.1007/s10549-006-9389-3", "type": "journal-article", "created": {"date-parts": [[2006, 9, 26]], "date-time": "2006-09-26T12:56:57Z", "timestamp": 1159275417000}, "page": "67-74", "source": "Crossref", "is-referenced-by-count": 10, "title": ["The 3\u2032 untranslated region C\u00a0>\u00a0T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation"], "prefix": "10.1007", "volume": "104", "author": [{"given": "Anna", "family": "Jakubowska", "sequence": "first", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Axel", "family": "Benner", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}, {"given": "Rodney J.", "family": "Scott", "sequence": "additional", "affiliation": []}, {"given": "Ute", "family": "Hamann", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 9, 27]]}, "reference": [{"key": "9389_CR1", "unstructured": "Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnet D, Bignon Y, Borg A, Hamann U, Haites N, Scott RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Zelada-Hedman M, the Breast Cancer Linkage Consortium (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676\u2013689", "DOI": "10.1086/301749", "doi-asserted-by": "crossref"}, {"key": "9389_CR2", "unstructured": "King MC, Marks JH, Mandell JB for New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646", "DOI": "10.1126/science.1088759", "doi-asserted-by": "crossref"}, {"key": "9389_CR3", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5", "volume": "73", "author": "EB Claus", "year": "1994", "unstructured": "Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643\u2013651", "journal-title": "Cancer"}, {"key": "9389_CR4", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1002/ajmg.1320560305", "volume": "56", "author": "DF Easton", "year": "1995", "unstructured": "Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265\u2013271", "journal-title": "Am J Hum Genet"}, {"key": "9389_CR5", "doi-asserted-by": "crossref", "first-page": "1963", "DOI": "10.1086/302922", "volume": "66", "author": "B Gorski", "year": "2000", "unstructured": "Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963\u20131968", "journal-title": "Am J Hum Genet"}, {"key": "9389_CR6", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1002/ijc.20162", "volume": "110", "author": "B Gorski", "year": "2004", "unstructured": "Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683\u2013686", "journal-title": "Int J Cancer"}, {"key": "9389_CR7", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1016/0888-7543(91)90126-Y", "volume": "11", "author": "JJ White", "year": "1991", "unstructured": "White JJ, Ledbetter DH, Eddy RL Jr, Shows TB, Stewart DA, Nuell MJ, Friedman V, Wood CM, Owens GA, McClung JK, Danner DB, Morton CC (1991) Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics 11:228\u2013230", "journal-title": "Genomics"}, {"key": "9389_CR8", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.1002/gcc.2870110109", "volume": "11", "author": "MA Nagai", "year": "1994", "unstructured": "Nagai MA, Yamamoto L, Salaorni S, Pacheco MM, Brentani MM, Barbosa EM, Brentani RR, Mazoyer S, Smith SA, Ponder BA, Mulligan LM (1994) Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer 11:58\u201362", "journal-title": "Genes Chromosomes Cancer"}, {"key": "9389_CR9", "doi-asserted-by": "crossref", "first-page": "3501", "DOI": "10.1038/sj.onc.1202684", "volume": "18", "author": "S Wang", "year": "1999", "unstructured": "Wang S, Nath N, Adlam M, Chellappan S (1999) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18:3501\u20133510", "journal-title": "Oncogene"}, {"key": "9389_CR10", "doi-asserted-by": "crossref", "first-page": "7447", "DOI": "10.1128/MCB.19.11.7447", "volume": "19", "author": "S Wang", "year": "1999", "unstructured": "Wang S, Nath N, Fusaro G, Chellappan S (1999) Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol 19:7447\u20137460", "journal-title": "Mol Cell Biol"}, {"key": "9389_CR11", "doi-asserted-by": "crossref", "first-page": "47853", "DOI": "10.1074/jbc.M305171200", "volume": "278", "author": "G Fusaro", "year": "2003", "unstructured": "Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S (2003) Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 278:47853\u201347861", "journal-title": "J Biol Chem"}, {"key": "9389_CR12", "first-page": "5251", "volume": "63", "author": "S Manjeshwar", "year": "2003", "unstructured": "Manjeshwar S, Branam DE, Lerner MR, Brackett DJ, Jupe ER (2003) Tumor suppression by the prohibitin gene 3\u2032 untranslated region RNA in human breast cancer. Cancer Res 63:5251\u20135256", "journal-title": "Cancer Res"}, {"key": "9389_CR13", "first-page": "871", "volume": "7", "author": "ER Jupe", "year": "1996", "unstructured": "Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell\u2019Orco RT (1996) Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3\u2032 untranslated region mutations. Cell Growth Differ 7:871\u2013878", "journal-title": "Cell Growth Differ"}, {"key": "9389_CR14", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1006/excr.1996.0120", "volume": "224", "author": "ER Jupe", "year": "1996", "unstructured": "Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell\u2019Orco RT (1996) The 3\u2032 untranslated region of prohibitin and cellular immortalization. Exp Cell Res 224:128\u2013135", "journal-title": "Exp Cell Res"}, {"key": "9389_CR15", "doi-asserted-by": "crossref", "first-page": "1588", "DOI": "10.1016/S0140-6736(00)04747-4", "volume": "357", "author": "ER Jupe", "year": "2001", "unstructured": "Jupe ER, Badgett AA, Neas BR, Craft MA, Mitchell DS, Resta R, Mulvihill JJ, Aston CE, Thompson LF (2001) Single nucleotide polymorphism in prohibitin 39 untranslated region and breast-cancer susceptibility. Lancet 357:1588\u20131589", "journal-title": "Lancet"}, {"key": "9389_CR16", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1016/S0140-6736(02)11043-9", "volume": "360", "author": "AB Spurdle", "year": "2002", "unstructured": "Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G (2002) Prohibitin 3\u2032 untranslated region polymorphism and breast cancer risk in Australian women. Lancet 360:925\u2013926", "journal-title": "Lancet"}, {"key": "9389_CR17", "first-page": "1273", "volume": "12", "author": "IG Campbell", "year": "2003", "unstructured": "Campbell IG, Allen J, Eccles DM (2003) Prohibitin 3\u2032 untranslated region polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:1273\u20131274", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "9389_CR18", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1007/BF00553174", "volume": "31", "author": "DK Lahiri", "year": "1993", "unstructured": "Lahiri DK, Schnabel B (1993) DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality. Biochem Genet 31:321\u2013328", "journal-title": "Biochem Genet"}, {"key": "9389_CR19", "author": "A Agresti", "first-page": "59", "year": "1990", "unstructured": "Agresti A (1990) Categorical data analysis. Wiley, New York, pp 59\u201367", "volume-title": "Categorical data analysis"}, {"key": "9389_CR20", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1002/sim.1047", "volume": "21", "author": "G Heinze", "year": "2002", "unstructured": "Heinze G, Schemper M (2002) A solution to the problem of separation in logistic regression. Stat Med 21:2409\u20132419", "journal-title": "Stat Med"}, {"key": "9389_CR21", "first-page": "639", "volume": "35", "author": "S Manjeshwar", "year": "2004", "unstructured": "Manjeshwar S, Lerner MR, Zang XP, Branam DE, Pento JT, Lane MM, Lightfoot SA, Brackett DJ, Jupe ER (2004) Expression of prohibitin 3\u2032 untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells. J Mol Histol 35:639\u2013646", "journal-title": "J Mol Histol"}, {"key": "9389_CR22", "unstructured": "Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod SA (2004) A protein truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet 41:e130", "DOI": "10.1136/jmg.2004.019430", "doi-asserted-by": "crossref"}, {"key": "9389_CR23", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1007/s10549-005-1409-1", "volume": "92", "author": "B Gorski", "year": "2005", "unstructured": "Gorski B, Cybulski C, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Stawicka M, Gozdecka-Grodecka S, Szwiec M, Urbanski K, Mitus J, Marczyk E, Dziuba J, Wandzel P, Surdyka D, Haus O, Janiszewska H, Debniak T, Toloczko-Grabarek A, Medrek K, Masojc B, Mierzejewski M, Kowalska E, Narod SA, Lubinski J (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92:19\u201324", "journal-title": "Breast Cancer Res Treat"}, {"key": "9389_CR24", "doi-asserted-by": "crossref", "first-page": "2251", "DOI": "10.1001/jama.286.18.2251", "volume": "286", "author": "MC King", "year": "2001", "unstructured": "King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B (2001) National surgical adjuvant breast and bowel project. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: national surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial. JAMA 286:2251\u20132256", "journal-title": "JAMA"}, {"key": "9389_CR25", "doi-asserted-by": "crossref", "first-page": "1876", "DOI": "10.1016/S0140-6736(00)03258-X", "volume": "356", "author": "SA Narod", "year": "2000", "unstructured": "Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H (2000) Hereditary breast cancer clinical study group. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876\u20131881", "journal-title": "Lancet"}, {"key": "9389_CR26", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1056/NEJM199901143400201", "volume": "340", "author": "LC Hartmann", "year": "1999", "unstructured": "Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77\u201384", "journal-title": "N Engl J Med"}, {"key": "9389_CR27", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1093/jnci/93.21.1633", "volume": "93", "author": "LC Hartmann", "year": "2001", "unstructured": "Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633\u20131637", "journal-title": "J Natl Cancer Inst"}, {"key": "9389_CR28", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1056/NEJM200107193450301", "volume": "345", "author": "H Meijers-Heijboer", "year": "2001", "unstructured": "Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164", "journal-title": "N Engl J Med"}, {"key": "9389_CR29", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1200/JCO.2004.04.188", "volume": "22", "author": "TR Rebbeck", "year": "2004", "unstructured": "Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van\u2019t Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055\u20131062", "journal-title": "J Clin Oncol"}, {"key": "9389_CR30", "unstructured": "Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, Prevention and Observation of Surgical End Points Study Group (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616\u20131622", "DOI": "10.1056/NEJMoa012158", "doi-asserted-by": "crossref"}, {"key": "9389_CR31", "doi-asserted-by": "crossref", "first-page": "1609", "DOI": "10.1056/NEJMoa020119", "volume": "346", "author": "ND Kauff", "year": "2002", "unstructured": "Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615", "journal-title": "N Engl J Med"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-006-9389-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T12:58:11Z", "timestamp": 1547384291000}, "score": 15.2579365, "issued": {"date-parts": [[2006, 9, 27]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2007, 6, 20]]}, "issue": "1"}, "alternative-id": ["9389"], "URL": "http://dx.doi.org/10.1007/s10549-006-9389-3", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2018, 12, 17]], "date-time": "2018-12-17T20:03:10Z", "timestamp": 1545076990083}, "reference-count": 43, "publisher": "Springer Nature", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1007/s10549-011-1635-7", "type": "journal-article", "created": {"date-parts": [[2011, 6, 23]], "date-time": "2011-06-23T12:06:14Z", "timestamp": 1308830774000}, "page": "937-945", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer"], "prefix": "10.1007", "volume": "132", "author": [{"given": "Pawel", "family": "Domagala", "sequence": "first", "affiliation": []}, {"given": "Dominika", "family": "Wokolorczyk", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}, {"given": "Wenancjusz", "family": "Domagala", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 6, 24]]}, "reference": [{"key": "1635_CR1", "doi-asserted-by": "crossref", "first-page": "925", "DOI": "10.1038/nrc2251", "volume": "7", "author": "L Antoni", "year": "2007", "unstructured": "Antoni L, Sodha N, Collins I, Garrett MD (2007) CHK2 kinase: cancer susceptibility and cancer therapy\u2014two sides of the same coin? Nat Rev Cancer 7:925\u2013936", "journal-title": "Nat Rev Cancer"}, {"key": "1635_CR2", "doi-asserted-by": "crossref", "first-page": "1379", "DOI": "10.1001/jama.295.12.1379", "volume": "295", "author": "T Walsh", "year": "2006", "unstructured": "Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379\u20131388", "journal-title": "JAMA"}, {"key": "1635_CR3", "doi-asserted-by": "crossref", "first-page": "8966", "DOI": "10.1158/0008-5472.CAN-06-1990", "volume": "66", "author": "N Sodha", "year": "2006", "unstructured": "Sodha N, Mantoni TS, Tavtigian SV, Eeles R, Garrett MD (2006) Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. Cancer Res 66:8966\u20138970", "journal-title": "Cancer Res"}, {"key": "1635_CR4", "doi-asserted-by": "crossref", "first-page": "2971", "DOI": "10.1074/jbc.M009727200", "volume": "276", "author": "X Wu", "year": "2001", "unstructured": "Wu X, Webster SR, Chen J (2001) Characterization of tumor-associated Chk2 mutations. J Biol Chem 276:2971\u20132974", "journal-title": "J Biol Chem"}, {"key": "1635_CR5", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1086/346094", "volume": "72", "author": "X Dong", "year": "2003", "unstructured": "Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN, Liu W (2003) Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 72:270\u2013280", "journal-title": "Am J Hum Genet"}, {"key": "1635_CR6", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1086/341943", "volume": "71", "author": "P Vahteristo", "year": "2002", "unstructured": "Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432\u2013438", "journal-title": "Am J Hum Genet"}, {"key": "1635_CR7", "doi-asserted-by": "crossref", "first-page": "5503", "DOI": "10.1038/sj.onc.1204811", "volume": "20", "author": "J Falck", "year": "2001", "unstructured": "Falck J, Lukas C, Protopopova M, Lukas J, Selivanova G, Bartek J (2001) Functional impact of concomitant versus alternative defects in the Chk2\u2013p53 tumour suppressor pathway. Oncogene 20:5503\u20135510", "journal-title": "Oncogene"}, {"key": "1635_CR8", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1038/35071124", "volume": "410", "author": "J Falck", "year": "2001", "unstructured": "Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J (2001) The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410:842\u2013847", "journal-title": "Nature"}, {"key": "1635_CR9", "doi-asserted-by": "crossref", "first-page": "1045", "DOI": "10.1016/S1097-2765(02)00527-0", "volume": "9", "author": "J Li", "year": "2002", "unstructured": "Li J, Williams BL, Haire LF, Goldberg M, Wilker E, Durocher D, Yaffe MB, Jackson SP, Smerdon SJ (2002) Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. Mol Cell 9:1045\u20131054", "journal-title": "Mol Cell"}, {"key": "1635_CR10", "doi-asserted-by": "crossref", "first-page": "543", "DOI": "10.1002/ijc.20299", "volume": "111", "author": "O Kilpivaara", "year": "2004", "unstructured": "Kilpivaara O, Vahteristo P, Falck J, Syrjakoski K, Eerola H, Easton D, Bartkova J, Lukas J, Heikkila P, Aittomaki K, Holli K, Blomqvist C, Kallioniemi OP, Bartek J, Nevanlinna H (2004) CHEK2 variant I157T may be associated with increased breast cancer risk. Int J Cancer 111:543\u2013547", "journal-title": "Int J Cancer"}, {"key": "1635_CR11", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1399-0004.2010.01402.x", "volume": "78", "author": "SA Narod", "year": "2010", "unstructured": "Narod SA (2010) Testing for CHEK2 in the cancer genetics clinic: ready for prime time? Clin Genet 78:1\u20137", "journal-title": "Clin Genet"}, {"key": "1635_CR12", "doi-asserted-by": "crossref", "first-page": "1131", "DOI": "10.1086/426403", "volume": "75", "author": "C Cybulski", "year": "2004", "unstructured": "Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131\u20131135", "journal-title": "Am J Hum Genet"}, {"key": "1635_CR13", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1007/s10549-004-3778-2", "volume": "90", "author": "T Huzarski", "year": "2005", "unstructured": "Huzarski T, Cybulski C, Domagala W, Gronwald J, Byrski T, Szwiec M, Woyke S, Narod SA, Lubinski J (2005) Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res Treat 90:187\u2013189", "journal-title": "Breast Cancer Res Treat"}, {"key": "1635_CR14", "doi-asserted-by": "crossref", "first-page": "4832", "DOI": "10.1158/1078-0432.CCR-06-0158", "volume": "12", "author": "C Cybulski", "year": "2006", "unstructured": "Cybulski C, Gorski B, Huzarski T, Byrski T, Gronwald J, Debniak T, Wokolorczyk D, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubinski J (2006) CHEK2-positive breast cancers in young Polish women. Clin Cancer Res 12:4832\u20134835", "journal-title": "Clin Cancer Res"}, {"key": "1635_CR15", "doi-asserted-by": "crossref", "first-page": "731", "DOI": "10.1136/jmg.2004.019737", "volume": "41", "author": "GH Bock de", "year": "2004", "unstructured": "de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG (2004) Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant. J Med Genet 41:731\u2013735", "journal-title": "J Med Genet"}, {"key": "1635_CR16", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1111/j.1399-0004.2008.01111.x", "volume": "75", "author": "C Cybulski", "year": "2009", "unstructured": "Cybulski C, Huzarski T, Byrski T, Gronwald J, Debniak T, Jakubowska A, Gorski B, Wokolorczyk D, Masojc B, Narod SA, Lubinski J (2009) Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Clin Genet 75:72\u201378", "journal-title": "Clin Genet"}, {"key": "1635_CR17", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1038/35021093", "volume": "406", "author": "CM Perou", "year": "2000", "unstructured": "Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752", "journal-title": "Nature"}, {"key": "1635_CR18", "doi-asserted-by": "crossref", "first-page": "10869", "DOI": "10.1073/pnas.191367098", "volume": "98", "author": "T Sorlie", "year": "2001", "unstructured": "Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869\u201310874", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1635_CR19", "doi-asserted-by": "crossref", "first-page": "2492", "DOI": "10.1001/jama.295.21.2492", "volume": "295", "author": "LA Carey", "year": "2006", "unstructured": "Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492\u20132502", "journal-title": "JAMA"}, {"key": "1635_CR20", "doi-asserted-by": "crossref", "first-page": "1368", "DOI": "10.1158/1078-0432.CCR-07-1658", "volume": "14", "author": "MC Cheang", "year": "2008", "unstructured": "Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14:1368\u20131376", "journal-title": "Clin Cancer Res"}, {"key": "1635_CR21", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1097/PDM.0b013e31818d107b", "volume": "18", "author": "P Tang", "year": "2009", "unstructured": "Tang P, Skinner KA, Hicks DG (2009) Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol 18:125\u2013132", "journal-title": "Diagn Mol Pathol"}, {"key": "1635_CR22", "doi-asserted-by": "crossref", "first-page": "e1000279", "DOI": "10.1371/journal.pmed.1000279", "volume": "7", "author": "FM Blows", "year": "2010", "unstructured": "Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, Cheang MC, Gelmon K, Nielsen TO, Blomqvist C, Heikkila P, Heikkinen T, Nevanlinna H, Akslen LA, Begin LR, Foulkes WD, Couch FJ, Wang X, Cafourek V, Olson JE, Baglietto L, Giles GG, Severi G, McLean CA, Southey MC, Rakha E, Green AR, Ellis IO, Sherman ME, Lissowska J, Anderson WF, Cox A, Cross SS, Reed MW, Provenzano E, Dawson SJ, Dunning AM, Humphreys M, Easton DF, Garcia-Closas M, Caldas C, Pharoah PD, Huntsman D (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7:e1000279", "journal-title": "PLoS Med"}, {"key": "1635_CR23", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1007/s10549-006-9320-y", "volume": "102", "author": "C Cybulski", "year": "2007", "unstructured": "Cybulski C, Wokolorczyk D, Huzarski T, Byrski T, Gronwald J, Gorski B, Debniak T, Masojc B, Jakubowska A, van de Wetering T, Narod SA, Lubinski J (2007) A deletion in CHEK2 of 5,395\u00a0bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 102:119\u2013122", "journal-title": "Breast Cancer Res Treat"}, {"key": "1635_CR24", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1111/j.1365-2559.1991.tb00229.x", "volume": "19", "author": "CW Elston", "year": "1991", "unstructured": "Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403\u2013410", "journal-title": "Histopathology"}, {"key": "1635_CR25", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1007/s00428-010-0988-3", "volume": "458", "author": "P Domagala", "year": "2011", "unstructured": "Domagala P, Huzarski T, Lubinski J, Gugala K, Domagala W (2011) Immunophenotypic predictive profiling of BRCA1-associated breast cancer. Virchows Arch 458:55\u201364", "journal-title": "Virchows Arch"}, {"key": "1635_CR26", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1007/s10549-011-1441-2", "volume": "127", "author": "P Domagala", "year": "2011", "unstructured": "Domagala P, Huzarski T, Lubinski J, Gugala K, Domagala W (2011) PARP-1 expression in breast cancer including BRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy. Breast Cancer Res Treat 127:861\u2013869", "journal-title": "Breast Cancer Res Treat"}, {"key": "1635_CR27", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.3816/CCC.2002.n.005", "volume": "1", "author": "GG Chung", "year": "2002", "unstructured": "Chung GG, Kielhorn EP, Rimm DL (2002) Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarray. Clin Colorectal Cancer 1:237\u2013242", "journal-title": "Clin Colorectal Cancer"}, {"key": "1635_CR28", "unstructured": "Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncology/College of American Pathologists (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18\u201343"}, {"key": "1635_CR29", "first-page": "907", "volume": "134", "author": "ME Hammond", "year": "2010", "unstructured": "Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:907\u2013922", "journal-title": "Arch Pathol Lab Med"}, {"key": "1635_CR30", "doi-asserted-by": "crossref", "first-page": "5367", "DOI": "10.1158/1078-0432.CCR-04-0220", "volume": "10", "author": "TO Nielsen", "year": "2004", "unstructured": "Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367\u20135374", "journal-title": "Clin Cancer Res"}, {"key": "1635_CR31", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1002/ijc.21004", "volume": "116", "author": "DM Abd El-Rehim", "year": "2005", "unstructured": "Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116:340\u2013350", "journal-title": "Int J Cancer"}, {"key": "1635_CR32", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1016/j.critrevonc.2007.12.008", "volume": "67", "author": "V Durbecq", "year": "2008", "unstructured": "Durbecq V, Ameye L, Veys I, Paesmans M, Desmedt C, Sirtaine N, Sotiriou C, Bernard-Marty C, Nogaret JM, Piccart M, Larsimont D (2008) A significant proportion of elderly patients develop hormone-dependant \u201cluminal-B\u201d tumours associated with aggressive characteristics. Crit Rev Oncol Hematol 67:80\u201392", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "1635_CR33", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1093/jnci/djp082", "volume": "101", "author": "MC Cheang", "year": "2009", "unstructured": "Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101:736\u2013750", "journal-title": "J Natl Cancer Inst"}, {"key": "1635_CR34", "first-page": "444", "volume": "2", "author": "R Bhargava", "year": "2009", "unstructured": "Bhargava R, Striebel J, Beriwal S, Flickinger JC, Onisko A, Ahrendt G, Dabbs DJ (2009) Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers. Int J Clin Exp Pathol 2:444\u2013455", "journal-title": "Int J Clin Exp Pathol"}, {"key": "1635_CR35", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/j.molonc.2010.04.001", "volume": "4", "author": "KA Kwei", "year": "2010", "unstructured": "Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR (2010) Genomic instability in breast cancer: pathogenesis and clinical implications. Mol Oncol 4:255\u2013266", "journal-title": "Mol Oncol"}, {"key": "1635_CR36", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1002/ijc.20638", "volume": "113", "author": "O Kilpivaara", "year": "2005", "unstructured": "Kilpivaara O, Bartkova J, Eerola H, Syrjakoski K, Vahteristo P, Lukas J, Blomqvist C, Holli K, Heikkila P, Sauter G, Kallioniemi OP, Bartek J, Nevanlinna H (2005) Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer 113:575\u2013580", "journal-title": "Int J Cancer"}, {"key": "1635_CR37", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1016/j.radonc.2006.12.002", "volume": "82", "author": "A Meyer", "year": "2007", "unstructured": "Meyer A, Dork T, Sohn C, Karstens JH, Bremer M (2007) Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy. Radiother Oncol 82:349\u2013353", "journal-title": "Radiother Oncol"}, {"key": "1635_CR38", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1200/JCO.2006.06.3024", "volume": "25", "author": "MK Schmidt", "year": "2007", "unstructured": "Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, Smit VT, Peterse JL, van Leeuwen FE, Van\u2019t Veer LJ (2007) Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol 25:64\u201369", "journal-title": "J Clin Oncol"}, {"key": "1635_CR39", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1200/JCO.2005.05.5160", "volume": "25", "author": "M Weischer", "year": "2007", "unstructured": "Weischer M, Bojesen SE, Tybjaerg-Hansen A, Axelsson CK, Nordestgaard BG (2007) Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 25:57\u201363", "journal-title": "J Clin Oncol"}, {"key": "1635_CR40", "doi-asserted-by": "crossref", "first-page": "2517", "DOI": "10.1002/1097-0142(19881215)62:12<2517::AID-CNCR2820621211>3.0.CO;2-9", "volume": "62", "author": "B Chevallier", "year": "1988", "unstructured": "Chevallier B, Heintzmann F, Mosseri V, Dauce JP, Bastit P, Graic Y, Brunelle P, Basuyau JP, Comoz M, Asselain B (1988) Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis. Cancer 62:2517\u20132524", "journal-title": "Cancer"}, {"key": "1635_CR41", "doi-asserted-by": "crossref", "first-page": "542", "DOI": "10.1200/JCO.2007.12.5922", "volume": "26", "author": "M Weischer", "year": "2008", "unstructured": "Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG (2008) CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 26:542\u2013548", "journal-title": "J Clin Oncol"}, {"key": "1635_CR42", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1200/JCO.2007.13.8503", "volume": "26", "author": "K Offit", "year": "2008", "unstructured": "Offit K, Garber JE (2008) Time to check CHEK2 in families with breast cancer? J Clin Oncol 26:519\u2013520", "journal-title": "J Clin Oncol"}, {"key": "1635_CR43", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1111/j.1399-0004.2010.01444.x", "volume": "78", "author": "M Robson", "year": "2010", "unstructured": "Robson M (2010) CHEK2, breast cancer, and the understanding of clinical utility. Clin Genet 78:8\u201310", "journal-title": "Clin Genet"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-011-1635-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T01:59:37Z", "timestamp": 1497923977000}, "score": 14.8203745, "issued": {"date-parts": [[2011, 6, 24]]}, "references-count": 43, "journal-issue": {"published-print": {"date-parts": [[2012, 4]]}, "issue": "3"}, "alternative-id": ["1635"], "URL": "http://dx.doi.org/10.1007/s10549-011-1635-7", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 7]], "date-time": "2018-05-07T23:32:47Z", "timestamp": 1525735967372}, "reference-count": 39, "publisher": "Springer Nature", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mol Biol Rep"], "published-print": {"date-parts": [[2013, 12]]}, "DOI": "10.1007/s11033-013-2775-0", "type": "journal-article", "created": {"date-parts": [[2013, 9, 25]], "date-time": "2013-09-25T00:59:33Z", "timestamp": 1380070773000}, "page": "6619-6623", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families"], "prefix": "10.1007", "volume": "40", "author": [{"given": "Helena", "family": "Rudnicka", "sequence": "first", "affiliation": []}, {"given": "Tadeusz", "family": "Debniak", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "Gorski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 9, 25]]}, "reference": [{"key": "2775_CR1", "doi-asserted-by": "crossref", "first-page": "1963", "DOI": "10.1086/302922", "volume": "66", "author": "B G\u00f3rski", "year": "2000", "unstructured": "G\u00f3rski B, Byrski T, Huzarski T, Jakubowska A et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963\u20131968", "journal-title": "Am J Hum Genet"}, {"key": "2775_CR2", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1002/1098-1004(200012)16:6<482::AID-HUMU5>3.0.CO;2-O", "volume": "16", "author": "E Grzybowska", "year": "2000", "unstructured": "Grzybowska E, Zientek H, Jasinska A et al (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16:482\u2013490", "journal-title": "Hum Mutat"}, {"key": "2775_CR3", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1002/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G", "volume": "15", "author": "M Looij van Der", "year": "2000", "unstructured": "van Der Looij M, Wysocka B, Brozek I et al (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15:480\u2013481", "journal-title": "Hum Mutat"}, {"key": "2775_CR4", "doi-asserted-by": "crossref", "first-page": "e57", "DOI": "10.1093/nar/gnf056", "volume": "30", "author": "JP Schouten", "year": "2002", "unstructured": "Schouten JP, McElgunn CJ, Waaijer R et al (2002) Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57", "journal-title": "Nucleic Acids Res"}, {"key": "2775_CR5", "first-page": "3", "volume": "57", "author": "N Puget", "year": "1997", "unstructured": "Puget N, Torchard D, Serova\u2013Sinilnikova OM et al (1997) A 1-kb Alu-mediated germline deletion removing BRCA1 exon 17. Cancer Res 57:3\u2013828", "journal-title": "Cancer Res"}, {"key": "2775_CR6", "unstructured": "HGMB-The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff: http://www.hgmd.cf.ac.uk"}, {"key": "2775_CR7", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1093/hmg/ddg120", "volume": "12", "author": "M Montagna", "year": "2003", "unstructured": "Montagna M, Dalla Palma M, Menin C et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055\u20131061. doi: 10.1093/hmg/ddg120", "journal-title": "Hum Mol Genet"}, {"key": "2775_CR8", "first-page": "1449", "volume": "63", "author": "FB Hogervorst", "year": "2003", "unstructured": "Hogervorst FB, Nederlof PM, Gille JJ et al (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449\u20131453", "journal-title": "Cancer Res"}, {"key": "2775_CR9", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1007/s10549-010-0817-z", "volume": "125", "author": "MD Sluiter", "year": "2011", "unstructured": "Sluiter MD, van Rensburg EJ (2011) Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 125:325\u2013349. doi: 10.1007/s10549-010-0817-z", "journal-title": "Breast Cancer Res Treat"}, {"key": "2775_CR10", "first-page": "263", "volume": "19", "author": "M Ratajska", "year": "2008", "unstructured": "Ratajska M, Brozek I, Senkus\u2013Konefka E et al (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19:263\u2013268", "journal-title": "Oncol Rep"}, {"key": "2775_CR11", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1002/humu.1164", "volume": "18", "author": "A Jakubowska", "year": "2001", "unstructured": "Jakubowska A, G\u00f3rski B, Byrski T et al (2001) Detection of germline mutations in the BRCA1 gene by RNA-based sequencing. Hum Mutat 18:149\u2013156", "journal-title": "Hum Mutat"}, {"key": "2775_CR12", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1007/s004390100505", "volume": "109", "author": "JT denDunnen", "year": "2001", "unstructured": "denDunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121\u2013124", "journal-title": "Hum Genet"}, {"key": "2775_CR13", "unstructured": "ReapetMasker: http://www.repeatmasker.org"}, {"key": "2775_CR14", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1002/gcc.20342", "volume": "45", "author": "S Agata", "year": "2006", "unstructured": "Agata S, Viel A, Della Puppa L, Cortesi L et al (2006) Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosom Cancer 45:791\u2013797", "journal-title": "Genes Chromosom Cancer"}, {"key": "2775_CR15", "doi-asserted-by": "crossref", "first-page": "534", "DOI": "10.1002/humu.9291", "volume": "24", "author": "C Hartmann", "year": "2004", "unstructured": "Hartmann C, John AL, Klaes R et al (2004) Large BRCA1 gene deletions are found in 3\u00a0% of German high-risk breast cancer families. Hum Mutat 24:534", "journal-title": "Hum Mutat"}, {"key": "2775_CR16", "doi-asserted-by": "crossref", "first-page": "6841", "DOI": "10.1038/sj.onc.1205685", "volume": "21", "author": "S Gad", "year": "2002", "unstructured": "Gad S, Caux\u2013Moncoutier V, Pag\u00e8s\u2013Berhouet S et al (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841\u20136847", "journal-title": "Oncogene"}, {"key": "2775_CR17", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1186/1471-2350-8-32", "volume": "8", "author": "P Vasickova", "year": "2007", "unstructured": "Vasickova P, Machackova E, Lukesova M et al (2007) High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet 8:32. doi: 10.1186/1471-2350-8-32", "journal-title": "BMC Med Genet"}, {"key": "2775_CR18", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1016/j.cancergencyto.2005.12.016", "volume": "168", "author": "M Thomassen", "year": "2006", "unstructured": "Thomassen M, Gerdes AM, Cruger D et al (2006) Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark. Cancer Genet Cytogenet 168:168\u2013171", "journal-title": "Cancer Genet Cytogenet"}, {"key": "2775_CR19", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1186/1471-2350-9-83", "volume": "9", "author": "M Krajc", "year": "2008", "unstructured": "Krajc M, Teugels E, Zgajnar J et al (2008) Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet 9:83. doi: 10.1186/1471-2350-9-83", "journal-title": "BMC Med Genet"}, {"key": "2775_CR20", "doi-asserted-by": "crossref", "first-page": "1379", "DOI": "10.1001/jama.295.12.1379", "volume": "295", "author": "T Walsh", "year": "2006", "unstructured": "Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379\u20131388", "journal-title": "JAMA"}, {"key": "2775_CR21", "doi-asserted-by": "crossref", "first-page": "7006", "DOI": "10.1158/0008-5472.CAN-08-0599", "volume": "68", "author": "MD Palma", "year": "2008", "unstructured": "Palma MD, Domchek SM, Stopfer J et al (2008) The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res 68:7006\u20137014. doi: 10.1158/0008-5472", "journal-title": "Cancer Res"}, {"key": "2775_CR22", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1007/s10689-008-9216-6", "volume": "8", "author": "T Distelman\u2013Menachem", "year": "2009", "unstructured": "Distelman\u2013Menachem T, Shapira T, Laitman Y et al (2009) Analysis of BRCA1/BRCA2 genes\u2019 contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women. Fam Cancer 8:127\u2013133. doi: 10.1007/s10689-008-9216-6", "journal-title": "Fam Cancer"}, {"key": "2775_CR23", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1007/s10549-010-0818-y", "volume": "123", "author": "ZK Stadler", "year": "2011", "unstructured": "Stadler ZK, Saloustros E, Hansen NA et al (2011) Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Breast Cancer Res Treat 123:581\u2013585. doi: 10.1007/s10549-010-0818-y", "journal-title": "Breast Cancer Res Treat"}, {"key": "2775_CR24", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1007/s10549-010-0745-y", "volume": "124", "author": "I Ticha", "year": "2010", "unstructured": "Ticha I, Kleibl Z, Stribrna J et al (2010) Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat 124:337\u2013347. doi: 10.1007/s10549-010-0745-y", "journal-title": "Breast Cancer Res Treat"}, {"key": "2775_CR25", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1007/s13167-010-0037-y", "volume": "1", "author": "R Janavi\u010dius", "year": "2010", "unstructured": "Janavi\u010dius R (2010) Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1:397\u2013412. doi: 10.1007/s13167-010-0037-y", "journal-title": "EPMA J"}, {"key": "2775_CR26", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1038/ng1197-341", "volume": "17", "author": "A Petrij\u2013Bosch", "year": "1997", "unstructured": "Petrij\u2013Bosch A, Peelen T, van Vliet M et al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341\u2013345", "journal-title": "Nat Genet"}, {"key": "2775_CR27", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1002/gcc.20189", "volume": "43", "author": "BC Hendrickson", "year": "2005", "unstructured": "Hendrickson BC, Judkins T, Ward B et al (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. Genes Chromosom Cancer 43:309\u2013313", "journal-title": "Genes Chromosom Cancer"}, {"key": "2775_CR28", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1002/humu.20169", "volume": "25", "author": "S Mazoyer", "year": "2005", "unstructured": "Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415\u2013422", "journal-title": "Hum Mutat"}, {"key": "2775_CR29", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1054/bjoc.1999.0892", "volume": "82", "author": "T Peelen", "year": "2000", "unstructured": "Peelen T, van Vliet M, Bosch A et al (2000) Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families. Br J Cancer 82:151\u2013156", "journal-title": "Br J Cancer"}, {"key": "2775_CR30", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.1016/S0165-4608(01)00437-X", "volume": "129", "author": "J Lahti\u2013Domenici", "year": "2001", "unstructured": "Lahti\u2013Domenici J, Rapakko K, P\u00e4\u00e4kk\u00f6nen K et al (2001) Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet Cytogenet 129:120\u2013123", "journal-title": "Cancer Genet Cytogenet"}, {"key": "2775_CR31", "doi-asserted-by": "crossref", "first-page": "e64", "DOI": "10.1136/jmg.2005.032789", "volume": "42", "author": "S Agata", "year": "2005", "unstructured": "Agata S, Dalla Palma M, Callegaro M et al (2005) Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet 42:e64. doi: 10.1136/jmg.2005.032789", "journal-title": "J Med Genet"}, {"issue": "22", "key": "2775_CR32", "doi-asserted-by": "crossref", "first-page": "8143", "DOI": "10.1158/0008-5472.CAN-04-2467", "volume": "64", "author": "I Tournier", "year": "2004", "unstructured": "Tournier I, Paillerets BB, Sobol H et al (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64(22):8143\u20138147", "journal-title": "Cancer Res"}, {"key": "2775_CR33", "doi-asserted-by": "crossref", "first-page": "e49", "DOI": "10.1136/jmg.2005.040212", "volume": "43", "author": "F Casilli", "year": "2006", "unstructured": "Casilli F, Tournier I, Sinilnikova OM et al (2006) The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet 43:e49", "journal-title": "J Med Genet"}, {"key": "2775_CR34", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1007/s10549-006-9376-8", "volume": "103", "author": "S Guti\u00e9rrez\u2013Enr\u00edquez", "year": "2007", "unstructured": "Guti\u00e9rrez\u2013Enr\u00edquez S, de la Hoya M, Mart\u00ednez\u2013Bouzas C et al (2007) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res Treat 103:103\u2013107. doi: 10.1007/s10549-006-9376-8", "journal-title": "Breast Cancer Res Treat"}, {"key": "2775_CR35", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1007/s10549-009-0613-9", "volume": "122", "author": "J Del Valle", "year": "2009", "unstructured": "Del Valle J, Feliubadalo L, Nadal M et al (2009) Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes. Breast Cancer Res Treat 122:733\u2013743. doi: 10.1007/s10549-009-0613-9", "journal-title": "Breast Cancer Res Treat"}, {"key": "2775_CR36", "first-page": "1372", "volume": "58", "author": "M Nordling", "year": "1998", "unstructured": "Nordling M, Karlsson P, Wahlstr\u00f6m et al (1998) A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 58:1372\u20131375", "journal-title": "Cancer Res"}, {"key": "2775_CR37", "doi-asserted-by": "crossref", "first-page": "2027", "DOI": "10.1200/JCO.2006.06.9443", "volume": "25", "author": "PM Machado", "year": "2007", "unstructured": "Machado PM, Brand\u00e3o RD, Cavaco BM et al (2007) Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J ClinOncol 25:2027\u20132034. doi: 10.1200/JCO.2006.06.9443", "journal-title": "J ClinOncol"}, {"key": "2775_CR38", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1007/s10549-008-9978-4", "volume": "114", "author": "A Peixoto", "year": "2009", "unstructured": "Peixoto A, Santos C, Rocha P et al (2009) The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal. Breast Cancer Res Treat 114:31\u201338. doi: 10.1007/s10549-008-9978-4", "journal-title": "Breast Cancer Res Treat"}, {"issue": "5", "key": "2775_CR39", "doi-asserted-by": "crossref", "first-page": "e31", "DOI": "10.1136/jmg.2004.027961", "volume": "42", "author": "AM Woodward", "year": "2005", "unstructured": "Woodward AM, Davis TA, Silva AG et al (2005) Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42(5):e31", "journal-title": "J Med Genet"}], "container-title": ["Molecular Biology Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11033-013-2775-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T22:29:28Z", "timestamp": 1498084168000}, "score": 14.8203745, "issued": {"date-parts": [[2013, 9, 25]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[2013, 12]]}, "issue": "12"}, "alternative-id": ["2775"], "URL": "http://dx.doi.org/10.1007/s11033-013-2775-0", "relation": {"cites": []}, "ISSN": ["0301-4851", "1573-4978"], "issn-type": [{"value": "0301-4851", "type": "print"}, {"value": "1573-4978", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 1, 3]], "date-time": "2019-01-03T07:25:01Z", "timestamp": 1546500301682}, "reference-count": 21, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2010, 1, 20]]}, "DOI": "10.1200/jco.2008.20.7019", "type": "journal-article", "created": {"date-parts": [[2009, 12, 15]], "date-time": "2009-12-15T03:07:08Z", "timestamp": 1260846428000}, "page": "375-379", "source": "Crossref", "is-referenced-by-count": 264, "title": ["Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy"], "prefix": "10.1200", "volume": "28", "author": [{"given": "Tomasz", "family": "Byrski", "sequence": "first", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Ewa", "family": "Grzybowska", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Magdalena", "family": "Budryk", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Malgorzata", "family": "Stawicka", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Tomasz", "family": "Mierzwa", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Marek", "family": "Szwiec", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Rafal", "family": "Wi\u015bniowski", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Monika", "family": "Siolek", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Rebecca", "family": "Dent", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}, {"given": "Steven", "family": "Narod", "sequence": "additional", "affiliation": [{"name": "From the Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin; Department of Tumor Biology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice; Prophylactic and Epidemiology Center, Pozna\u0144; Regional Oncology Hospital, Bydgoszcz; Regional Oncology Center, Opole; Regional Oncology Hospital, Bielsko Bia\u0142a; Holy Cross Oncololgy Center, Kielce, Poland; Odette Cancer Centre, Sunnybrook Regional Cancer Centre; and Womens..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdf/10.1200/JCO.2008.20.7019", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 4]], "date-time": "2017-04-04T02:04:55Z", "timestamp": 1491271495000}, "score": 14.326284, "issued": {"date-parts": [[2010, 1, 20]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2010, 1, 20]]}, "issue": "3"}, "alternative-id": ["10.1200/JCO.2008.20.7019"], "URL": "http://dx.doi.org/10.1200/jco.2008.20.7019", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T10:07:51Z", "timestamp": 1525774071937}, "reference-count": 16, "publisher": "Springer Nature", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 12, 15]], "date-time": "2017-12-15T00:00:00Z", "timestamp": 1513296000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2018, 4]]}, "DOI": "10.1007/s10549-017-4605-x", "type": "journal-article", "created": {"date-parts": [[2017, 12, 15]], "date-time": "2017-12-15T05:21:59Z", "timestamp": 1513315319000}, "page": "513-521", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Predictors of survival for breast cancer patients with a BRCA1 mutation"], "prefix": "10.1007", "volume": "168", "author": [{"given": "Steven A.", "family": "Narod", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Elzbieta", "family": "Marczyk", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Marek", "family": "Szwiec", "sequence": "additional", "affiliation": []}, {"given": "Rafal", "family": "Wisniowski", "sequence": "additional", "affiliation": []}, {"given": "Bozena", "family": "Birkenfeld", "sequence": "additional", "affiliation": []}, {"given": "Ewa", "family": "Kilar", "sequence": "additional", "affiliation": []}, {"given": "Robert", "family": "Sibilski", "sequence": "additional", "affiliation": []}, {"given": "Ping", "family": "Sun", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubinski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 12, 15]]}, "reference": [{"issue": "7", "key": "4605_CR1", "doi-asserted-by": "crossref", "first-page": "776", "DOI": "10.1038/bjc.2016.249", "volume": "115", "author": "JG Jonasson", "year": "2016", "unstructured": "Jonasson JG, Stefansson OA, Johannsson OT, Sigurdsson H, Agnarsson BA, Olafsdottir GH, Alexiusdottir KK, Stefansdottir H, Munoz Mitev R, Olafsdottir K, Olafsdottir K, Arason A, Stefansdottir V, Olafsdottir EJ, Barkardottir RB, Eyfjord JE, Narod SA, Tryggvad\u00f3ttir L (2016) Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers. Br J Cancer 115(7):776\u2013783", "journal-title": "Br J Cancer"}, {"issue": "6", "key": "4605_CR2", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1016/S1470-2045(15)70142-7", "volume": "16", "author": "C Cybulski", "year": "2015", "unstructured": "Cybulski C, Klu\u017aniak W, Huzarski T, Woko\u0142orczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, D\u0119bniak T, G\u00f3rski B, Sopik V, Akbari MR, Sun P, Gronwald J, Narod SA (2015) Lubi\u0144ski J; Polish Hereditary Breast Cancer Consortium. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol 16(6):638\u2013644", "journal-title": "Lancet Oncol"}, {"key": "4605_CR3", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1023/A:1005830230664", "volume": "44", "author": "JN Marcus", "year": "1997", "unstructured": "Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Lenoir GM, Serova O, Lynch HT (1997) BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat 44:275\u2013277", "journal-title": "Breast Cancer Res Treat"}, {"key": "4605_CR4", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1093/jnci/90.15.1138", "volume": "90", "author": "SR Lakhani", "year": "1998", "unstructured": "Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storger-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D, Bignon YJ, Struewing JP, Spurr NK, Bishop DT, Klijn JG, Devilee P et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138\u20131145", "journal-title": "J Natl Cancer Inst"}, {"issue": "1", "key": "4605_CR5", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1007/s10549-013-2429-x", "volume": "138", "author": "SA Narod", "year": "2013", "unstructured": "Narod SA, Metcalfe K, Lynch HT, Ghadirian P, Robidoux A, Tung N, Gaughan E, Kim-Sing C, Olopade OI, Foulkes WD, Robson M, Offit K, Jakubowska A, Byrski T, Huzarski T, Sun P, Lubinski J (2013) Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? Breast Cancer Res Treat 138(1):273\u2013279", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "4605_CR6", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1007/s10549-014-3100-x", "volume": "147", "author": "T Byrski", "year": "2014", "unstructured": "Byrski T, Huzarski T, Dent R, Marczyk E, Jasiowka M, Gronwald J, Jakubowicz J, Cybulski C, Wisniowski R, Godlewski D, Lubinski J, Narod SA (2014) Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 147(2):401\u2013405", "journal-title": "Breast Cancer Res Treat"}, {"issue": "28", "key": "4605_CR7", "doi-asserted-by": "crossref", "first-page": "3739", "DOI": "10.1200/JCO.2011.35.2682", "volume": "29", "author": "B Arun", "year": "2011", "unstructured": "Arun B, Bayraktar S, Liu DD, Gutierrez Barrera AM, Atchley D, Pusztai L, Litton JK, Valero V, Meric-Bernstam F, Hortobagyi GN, Albarracin C (2011) Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience. J Clin Oncol 29(28):3739\u20133746", "journal-title": "J Clin Oncol"}, {"issue": "15", "key": "4605_CR8", "doi-asserted-by": "crossref", "first-page": "1547", "DOI": "10.1200/JCO.2013.53.2820", "volume": "32", "author": "AP Finch", "year": "2014", "unstructured": "Finch AP, Lubinski J, M\u00f8ller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA (2014) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 32(15):1547\u20131553", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "4605_CR9", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1001/jamaoncol.2015.0658", "volume": "1", "author": "K Metcalfe", "year": "2015", "unstructured": "Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA (2015) Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. JAMA Oncol. 1(3):306\u2013313", "journal-title": "JAMA Oncol."}, {"issue": "2", "key": "4605_CR10", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1007/s10549-016-3749-4", "volume": "156", "author": "T Huzarski", "year": "2016", "unstructured": "Huzarski T, Byrski T, Gronwald J, Cybulski C, Oszurek O, Szwiec M, Guga\u0142a K, Stawicka M, Morawiec Z, Mierzwa T, Falco M, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, Sio\u0142ek M, Surdyka D, Wi\u015bniowski R, Posmyk M, Domaga\u0142a P, Sun P, Lubi\u0144ski J (2016) Narod\u00a0SA; Polish Breast Cancer Consortium. The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 156(2):371\u2013378", "journal-title": "Breast Cancer Res Treat"}, {"issue": "6", "key": "4605_CR11", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1056/NEJMoa1706450", "volume": "377", "author": "M Robson", "year": "2017", "unstructured": "Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P (2017) Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N Engl J Med 377(6):523\u2013533", "journal-title": "N Engl J Med"}, {"key": "4605_CR12", "doi-asserted-by": "crossref", "first-page": "1963", "DOI": "10.1086/302922", "volume": "66", "author": "B G\u00f3rski", "year": "2000", "unstructured": "G\u00f3rski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanski A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J (2000) Founder mutations in BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66:1963\u20131968", "journal-title": "Am J Hum Genet"}, {"issue": "10", "key": "4605_CR13", "doi-asserted-by": "crossref", "first-page": "1714", "DOI": "10.1002/cncr.30528", "volume": "123", "author": "KC Long Roche", "year": "2017", "unstructured": "Long Roche KC, Abu-Rustum NR, Nourmoussavi M, Zivanovic O (2017) Risk-reducing salpingectomy: let us be opportunistic. Cancer 123(10):1714\u20131720", "journal-title": "Cancer"}, {"issue": "1", "key": "4605_CR14", "doi-asserted-by": "crossref", "first-page": "1093", "DOI": "10.1038/s41467-017-00962-1", "volume": "8", "author": "SI Labidi-Galy", "year": "2017", "unstructured": "Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, Tille JC, Bowden M, Ayhan A, Wood LD, Scharpf RB, Kurman R, Wang TL, Shih IM, Karchin R, Drapkin R, Velculescu VE (2017) High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun 8(1):1093", "journal-title": "Nat Commun"}, {"key": "4605_CR15", "author": "Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Coll\u00e9e JM, van Doorn HC, Gomez Garcia EB, Kets CM, van Leeuwen FE, Meijers-Heijboer HE, Mourits MJ, van Os TA, Vasen HF, Verhoef S, Rookus MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands", "year": "2015", "unstructured": "Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Coll\u00e9e JM, van Doorn HC, Gomez Garcia EB, Kets CM, van Leeuwen FE, Meijers-Heijboer HE, Mourits MJ, van Os TA, Vasen HF, Verhoef S, Rookus MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands (2015) Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst. \n                        https://doi.org/10.1093/jnci/djv033\n                        \n                    \n                ", "journal-title": "J Natl Cancer Inst", "DOI": "10.1093/jnci/djv033", "doi-asserted-by": "publisher"}, {"key": "4605_CR16", "author": "J Kotsopoulos", "year": "2016", "unstructured": "Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, Eng C, Pal T, Evans G, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group (2016) Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 Mutation Carriers. J Natl Cancer. \n                        https://doi.org/10.1093/jnci/djw177\n                        \n                    \n                ", "journal-title": "J Natl Cancer", "DOI": "10.1093/jnci/djw177", "doi-asserted-by": "publisher"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s10549-017-4605-x/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-017-4605-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-017-4605-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 5]], "date-time": "2018-03-05T12:57:23Z", "timestamp": 1520254643000}, "score": 12.700592, "issued": {"date-parts": [[2017, 12, 15]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2018, 4]]}, "issue": "2"}, "alternative-id": ["4605"], "URL": "http://dx.doi.org/10.1007/s10549-017-4605-x", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T00:47:21Z", "timestamp": 1525308441225}, "reference-count": 0, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hered Cancer Clin Pract", "Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1186/1897-4287-4-1-58", "type": "journal-article", "created": {"date-parts": [[2010, 3, 11]], "date-time": "2010-03-11T19:15:35Z", "timestamp": 1268334935000}, "page": "58", "source": "Crossref", "is-referenced-by-count": 4, "title": ["A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet"], "prefix": "10.1186", "volume": "4", "author": [{"given": "Tomasz", "family": "Huzarski", "sequence": "first", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "El\u017cbieta", "family": "Kowalska", "sequence": "additional", "affiliation": []}, {"given": "Stanis\u0142aw", "family": "Zaj\u0105czek", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "Jowita", "family": "Huzarska", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Steven A", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:13:11Z", "timestamp": 1463418791000}, "score": 12.700592, "issued": {"date-parts": [[2006]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006]]}, "issue": "1"}, "alternative-id": ["1897-4287-4-1-58"], "URL": "http://dx.doi.org/10.1186/1897-4287-4-1-58", "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T08:23:06Z", "timestamp": 1525508586988}, "reference-count": 0, "publisher": "Springer Nature", "issue": "Suppl 3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hered Cancer Clin Pract", "Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2012]]}, "DOI": "10.1186/1897-4287-10-s3-a8", "type": "journal-article", "created": {"date-parts": [[2012, 4, 20]], "date-time": "2012-04-20T10:15:36Z", "timestamp": 1334916936000}, "page": "A8", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Selenium (Se) and the risk of breast, ovarian and prostate cancers"], "prefix": "10.1186", "volume": "10", "author": [{"given": "Katarzyna", "family": "Jaworska", "sequence": "first", "affiliation": []}, {"given": "Anna", "family": "Jakubowska", "sequence": "additional", "affiliation": []}, {"given": "Katarzyna", "family": "Durda", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Pablo", "family": "Serrano-Fernandez", "sequence": "additional", "affiliation": []}, {"given": "Grzegorz", "family": "Sukiennicki", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Muszy\u0144ska", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Satish", "family": "Gupta", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Kaczmarek", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:12:08Z", "timestamp": 1463418728000}, "score": 12.700592, "issued": {"date-parts": [[2012]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012]]}, "issue": "Suppl 3"}, "alternative-id": ["1897-4287-10-S3-A8"], "URL": "http://dx.doi.org/10.1186/1897-4287-10-s3-a8", "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T08:23:06Z", "timestamp": 1525508586997}, "reference-count": 0, "publisher": "Springer Nature", "issue": "Suppl 3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hered Cancer Clin Pract", "Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2012]]}, "DOI": "10.1186/1897-4287-10-s3-a4", "type": "journal-article", "created": {"date-parts": [[2012, 4, 20]], "date-time": "2012-04-20T10:15:38Z", "timestamp": 1334916938000}, "page": "A4", "source": "Crossref", "is-referenced-by-count": 0, "title": ["CHEK2 mutations as markers for high risk of breast cancer"], "prefix": "10.1186", "volume": "10", "author": [{"given": "Cezary", "family": "Cybulski", "sequence": "first", "affiliation": []}, {"given": "Dominika", "family": "Woko\u0142orczyk", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Jakubowska", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Tadeusz", "family": "D\u0119bniak", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Blecharz", "sequence": "additional", "affiliation": []}, {"given": "S A", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:12:06Z", "timestamp": 1463418726000}, "score": 12.700592, "issued": {"date-parts": [[2012]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012]]}, "issue": "Suppl 3"}, "alternative-id": ["1897-4287-10-S3-A4"], "URL": "http://dx.doi.org/10.1186/1897-4287-10-s3-a4", "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T10:22:01Z", "timestamp": 1525342921509}, "update-to": [{"updated": {"date-parts": [[2007, 1, 18]], "date-time": "2007-01-18T00:00:00Z", "timestamp": 1169078400000}, "DOI": "10.1038/sj.ejhg.5201734", "type": "erratum", "label": "Erratum"}], "reference-count": 0, "publisher": "Springer Nature", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 1, 18]], "date-time": "2007-01-18T00:00:00Z", "timestamp": 1169078400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Eur J Hum Genet"], "published-print": {"date-parts": [[2007, 2]]}, "DOI": "10.1038/sj.ejhg.5201779", "type": "journal-article", "created": {"date-parts": [[2007, 1, 18]], "date-time": "2007-01-18T08:03:30Z", "timestamp": 1169107410000}, "page": "254-254", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Erratum: Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?"], "prefix": "10.1038", "volume": "15", "author": [{"given": "Cezary", "family": "Cybulski", "sequence": "first", "affiliation": []}, {"given": "Dominika", "family": "Woko\u0142orczyk", "sequence": "additional", "affiliation": []}, {"given": "J\u00f3zef", "family": "K\u0142adny", "sequence": "additional", "affiliation": []}, {"given": "Grzegorz", "family": "Kurzawski", "sequence": "additional", "affiliation": []}, {"given": "Joanna", "family": "Suchy", "sequence": "additional", "affiliation": []}, {"given": "Ewa", "family": "Grabowska", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "Tadeusz", "family": "D\u0119bniak", "sequence": "additional", "affiliation": []}, {"given": "Steven A", "family": "Narod", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 1, 18]]}, "container-title": ["European Journal of Human Genetics"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/5201779.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/5201779", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/5201779.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 17]], "date-time": "2017-11-17T18:29:38Z", "timestamp": 1510943378000}, "score": 12.700592, "issued": {"date-parts": [[2007, 1, 18]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 2]]}, "issue": "2"}, "alternative-id": ["BF5201779"], "URL": "http://dx.doi.org/10.1038/sj.ejhg.5201779", "ISSN": ["1018-4813", "1476-5438"], "issn-type": [{"value": "1018-4813", "type": "print"}, {"value": "1476-5438", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T13:14:24Z", "timestamp": 1525526064084}, "reference-count": 8, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1186/1897-4287-4-1-25", "type": "journal-article", "created": {"date-parts": [[2012, 7, 5]], "date-time": "2012-07-05T02:08:20Z", "timestamp": 1341454100000}, "page": "25", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Coverage of the Genetic Background of Breast Cancer in the Polish Population"], "prefix": "10.1186", "volume": "4", "author": [{"given": "Pablo", "family": "Serrano-Fern\u00e1ndez", "sequence": "first", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "Tadeusz", "family": "D\u0119bniak", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Jakubowska", "sequence": "additional", "affiliation": []}, {"given": "Oleg", "family": "Oszurek", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}, {"name": "Polish Hereditary Cancer Consortium", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "10.1186/1897-4287-4-1-25-B1", "DOI": "10.1002/ijc.20162", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B3", "DOI": "10.1002/(SICI)1098-1004(1999)14:1<92::AID-HUMU23>3.0.CO;2-2", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B4", "DOI": "10.1034/j.1399-0004.2001.600611.x", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B5", "DOI": "10.1002/ijc.1626", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B6", "DOI": "10.1007/s10549-005-1409-1", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B7", "DOI": "10.1007/s10549-004-1250-y", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B8", "DOI": "10.1136/jmg.2005.031476", "doi-asserted-by": "publisher"}, {"key": "10.1186/1897-4287-4-1-25-B9", "DOI": "10.1086/426403", "doi-asserted-by": "publisher"}], "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:13:08Z", "timestamp": 1463418788000}, "score": 12.700592, "issued": {"date-parts": [[2006]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2006]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1186/1897-4287-4-1-25", "relation": {"cites": []}, "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 5]], "date-time": "2018-05-05T13:14:04Z", "timestamp": 1525526044975}, "reference-count": 0, "publisher": "Springer Nature", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1186/1897-4287-4-1-56", "type": "journal-article", "created": {"date-parts": [[2012, 7, 5]], "date-time": "2012-07-05T00:12:27Z", "timestamp": 1341447147000}, "page": "56", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland"], "prefix": "10.1186", "volume": "4", "author": [{"given": "Jacek", "family": "Gronwald", "sequence": "first", "affiliation": []}, {"given": "Andrzej", "family": "Raczy\u0144ski", "sequence": "additional", "affiliation": []}, {"given": "Mariusz", "family": "Tarhoni", "sequence": "additional", "affiliation": []}, {"given": "Miros\u0142aw", "family": "Blachowski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Aleksandra", "family": "To\u0142oczko-Grabarek", "sequence": "additional", "affiliation": []}, {"given": "Tadeusz", "family": "D\u0119bniak", "sequence": "additional", "affiliation": []}, {"given": "Cezary", "family": "Cybulski", "sequence": "additional", "affiliation": []}, {"given": "Jowita", "family": "Huzarska", "sequence": "additional", "affiliation": []}, {"given": "Oleg", "family": "Oszurek", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:13:10Z", "timestamp": 1463418790000}, "score": 12.700592, "issued": {"date-parts": [[2006]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1186/1897-4287-4-1-56", "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T03:22:58Z", "timestamp": 1525404178436}, "reference-count": 5, "publisher": "Springer Nature", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2008, 11]]}, "DOI": "10.1007/s10549-007-9864-5", "type": "journal-article", "created": {"date-parts": [[2007, 12, 20]], "date-time": "2007-12-20T16:05:18Z", "timestamp": 1198166718000}, "page": "367-368", "source": "Crossref", "is-referenced-by-count": 12, "title": ["A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population"], "prefix": "10.1007", "volume": "112", "author": [{"given": "Cezary", "family": "Cybulski", "sequence": "first", "affiliation": []}, {"given": "Dominika", "family": "Woko\u0142orczyk", "sequence": "additional", "affiliation": []}, {"given": "Brt\u0142omiej", "family": "Gliniewicz", "sequence": "additional", "affiliation": []}, {"given": "Andrzej", "family": "Sikorski", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "Anna", "family": "Jakubowska", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Tadeusz", "family": "D\u0119bniak", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}, {"given": "Steven A.", "family": "Narod", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 12, 21]]}, "reference": [{"key": "9864_CR1", "first-page": "605", "volume": "39", "author": "T Sun", "year": "2007", "unstructured": "Sun T et\u00a0al (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39:605\u2013613", "journal-title": "Nat Genet"}, {"key": "9864_CR2", "first-page": "308", "volume": "6", "author": "RM Siegel", "year": "2006", "unstructured": "Siegel RM (2006) Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 6:308\u2013317", "journal-title": "Nat Rev Immunol"}, {"key": "9864_CR3", "first-page": "5436", "volume": "272", "author": "PK Ho", "year": "2005", "unstructured": "Ho PK, Hawkins CJ (2005) Mammalian initiator apoptotic caspases. FEBS J 272:5436\u20135453", "journal-title": "FEBS J"}, {"key": "9864_CR4", "unstructured": "Frank B et\u00a0al (2007) The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat. doi: 10.1007/s10549-007-9752-2"}, {"key": "9864_CR5", "first-page": "572", "volume": "16", "author": "C Cybulski", "year": "2007", "unstructured": "Cybulski C et\u00a0al (2007) Epistatic relationship between the cancer susceptibility genes CHEK2 and p27. Cancer Epidemiol Biomarkers Prev 16:572\u2013576", "journal-title": "Cancer Epidemiol Biomarkers Prev"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/s10549-007-9864-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2013, 3, 29]], "date-time": "2013-03-29T18:05:10Z", "timestamp": 1364580310000}, "score": 12.700592, "issued": {"date-parts": [[2007, 12, 21]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2008, 11]]}, "issue": "2"}, "alternative-id": ["9864"], "URL": "http://dx.doi.org/10.1007/s10549-007-9864-5", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T08:29:13Z", "timestamp": 1525422553465}, "reference-count": 21, "publisher": "Springer Nature", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 4, 8]], "date-time": "2008-04-08T00:00:00Z", "timestamp": 1207612800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BMC Cancer"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1186/1471-2407-8-90", "type": "journal-article", "created": {"date-parts": [[2008, 4, 8]], "date-time": "2008-04-08T18:13:34Z", "timestamp": 1207678414000}, "source": "Crossref", "is-referenced-by-count": 5, "title": ["Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism"], "prefix": "10.1186", "volume": "8", "author": [{"given": "Anna", "family": "Jakubowska", "sequence": "first", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Janusz", "family": "Menkiszak", "sequence": "additional", "affiliation": []}, {"given": "Bohdan", "family": "G\u00f3rski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Axel", "family": "Benner", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}, {"given": "Rodney J", "family": "Scott", "sequence": "additional", "affiliation": []}, {"given": "Ute", "family": "Hamann", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 4, 8]]}, "reference": [{"key": "1028_CR1", "doi-asserted-by": "publisher", "first-page": "1401", "DOI": "10.1056/NEJM199705153362001", "volume": "336", "author": "JP Struewing", "year": "1997", "unstructured": "Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997, 336: 1401-1408. 10.1056/NEJM199705153362001.", "journal-title": "N Engl J Med"}, {"key": "1028_CR2", "doi-asserted-by": "publisher", "first-page": "265", "DOI": "10.1002/ajmg.1320560305", "volume": "56", "author": "DF Easton", "year": "1995", "unstructured": "Easton DF, Ford D, Bishop DT, the Breast Cancer Linkage Consortium: Breast and ovarian cancer incidence in BRCA I-mutation carriers. Am J Hum Genet. 1995, 56: 265-271.", "journal-title": "Am J Hum Genet"}, {"key": "1028_CR3", "doi-asserted-by": "publisher", "first-page": "3501", "DOI": "10.1038/sj.onc.1202684", "volume": "18", "author": "S Wang", "year": "1999", "unstructured": "Wang S, Nath N, Adlam M, Chellappan S: Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. 1999, 18: 3501-3510. 10.1038/sj.onc.1202684.", "journal-title": "Oncogene"}, {"key": "1028_CR4", "doi-asserted-by": "publisher", "first-page": "7447", "DOI": "10.1128/MCB.19.11.7447", "volume": "19", "author": "S Wang", "year": "1999", "unstructured": "Wang S, Nath N, Fusaro G, Chellappan S: Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol. 1999, 19: 7447-7460.", "journal-title": "Mol Cell Biol"}, {"key": "1028_CR5", "doi-asserted-by": "publisher", "first-page": "47853", "DOI": "10.1074/jbc.M305171200", "volume": "278", "author": "G Fusaro", "year": "2003", "unstructured": "Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S: Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem. 2003, 278: 47853-47861. 10.1074/jbc.M305171200.", "journal-title": "J Biol Chem"}, {"key": "1028_CR6", "first-page": "5251", "volume": "63", "author": "S Manjeshwar", "year": "2003", "unstructured": "Manjeshwar S, Branam DE, Lerner MR, Brackett DJ, Jupe ER: Tumor suppression by the prohibitin gene 3' untranslated region RNA in human breast cancer. Cancer Res. 2003, 63: 5251-5256.", "journal-title": "Cancer Res"}, {"key": "1028_CR7", "first-page": "871", "volume": "7", "author": "ER Jupe", "year": "1996", "unstructured": "Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell'Orco RT: Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3' untranslated region mutations. Cell Growth Differ. 1996, 7: 871-878.", "journal-title": "Cell Growth Differ"}, {"key": "1028_CR8", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1006/excr.1996.0120", "volume": "224", "author": "ER Jupe", "year": "1996", "unstructured": "Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell'Orco RT: The 3' untranslated region of prohibitin and cellular immortalization. Exp Cell Res. 1996, 224: 128-135. 10.1006/excr.1996.0120.", "journal-title": "Exp Cell Res"}, {"key": "1028_CR9", "doi-asserted-by": "publisher", "first-page": "639", "DOI": "10.1007/s10735-004-2185-7", "volume": "35", "author": "S Manjeshwar", "year": "2004", "unstructured": "Manjeshwar S, Lerner MR, Zang XP, Branam DE, Pento JT, Lane MM, Lightfoot SA, Brackett DJ, Jupe ER: Expression of prohibitin 3' untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells. J Mol Histol. 2004, 35: 639-646. 10.1007/s10735-004-2185-7.", "journal-title": "J Mol Histol"}, {"key": "1028_CR10", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1007/s10549-006-9389-3", "volume": "104", "author": "A Jakubowska", "year": "2007", "unstructured": "Jakubowska A, Gronwald J, Gorski B, Huzarski T, Byrski T, Benner A, Lubinski J, Scott RJ, Hamann U: The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res Treat. 2007, 104: 67-74. 10.1007/s10549-006-9389-3.", "journal-title": "Breast Cancer Res Treat"}, {"key": "1028_CR11", "doi-asserted-by": "publisher", "first-page": "1963", "DOI": "10.1086/302922", "volume": "66", "author": "B Gorski", "year": "2000", "unstructured": "Gorski B, Byrski T, Huzarski T, Jakubowska A, Menkiszak J, Gronwald J, Pluzanska A, Bebenek M, Fischer-Maliszewska L, Grzybowska E, Narod SA, Lubinski J: Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet. 2000, 66: 1963-1968. 10.1086/302922.", "journal-title": "Am J Hum Genet"}, {"key": "1028_CR12", "doi-asserted-by": "publisher", "first-page": "683", "DOI": "10.1002/ijc.20162", "volume": "110", "author": "B Gorski", "year": "2004", "unstructured": "Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer. 2004, 110: 683-686. 10.1002/ijc.20162.", "journal-title": "Int J Cancer"}, {"key": "1028_CR13", "doi-asserted-by": "publisher", "first-page": "1588", "DOI": "10.1016/S0140-6736(00)04747-4", "volume": "357", "author": "ER Jupe", "year": "2001", "unstructured": "Jupe ER, Badgett AA, Neas BR, Craft MA, Mitchell DS, Resta R, Mulvihill JJ, Aston CE, Thompson LF: Single nucleotide polymorphism in prohibitin 3' untranslated region and breast-cancer susceptibility. Lancet. 2001, 357: 1588-1589. 10.1016/S0140-6736(00)04747-4.", "journal-title": "Lancet"}, {"key": "1028_CR14", "doi-asserted-by": "publisher", "first-page": "925", "DOI": "10.1016/S0140-6736(02)11043-9", "volume": "360", "author": "AB Spurdle", "year": "2002", "unstructured": "Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G: Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women. Lancet. 2002, 360: 925-926. 10.1016/S0140-6736(02)11043-9.", "journal-title": "Lancet"}, {"key": "1028_CR15", "first-page": "1273", "volume": "12", "author": "IG Campbell", "year": "2003", "unstructured": "Campbell IG, Allen J, Eccles DM: Prohibitin 3' untranslated region polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1273-1274.", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "1028_CR16", "doi-asserted-by": "publisher", "first-page": "1157", "DOI": "10.2307/2531743", "volume": "44", "author": "WD Dupont", "year": "1988", "unstructured": "Dupont WD: Power calculations for matched case-control studies. Biometrics. 1988, 44: 1157-1168. 10.2307/2531743.", "journal-title": "Biometrics"}, {"key": "1028_CR17", "doi-asserted-by": "publisher", "first-page": "2409", "DOI": "10.1002/sim.1047", "volume": "21", "author": "G Heinze", "year": "2002", "unstructured": "Heinze G, Schemper M: A solution to the problem of separation in logistic regression. Stat Med. 2002, 21: 2409-2419. 10.1002/sim.1047.", "journal-title": "Stat Med"}, {"key": "1028_CR18", "author": "R Development Core Team. R", "year": "2006", "unstructured": "R Development Core Team. R: A language and environment for statistical computing. 2006, R Foundation for Statistical Computing. Vienna, Austria", "volume-title": "A language and environment for statistical computing"}, {"key": "1028_CR19", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/S0090-8258(03)00193-8", "volume": "90", "author": "AB Spurdle", "year": "2003", "unstructured": "Spurdle AB, Purdie DM, Chen X, Chenevix-Trench G: The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer. Gynecol Oncol. 2003, 90: 45-149. 10.1016/S0090-8258(03)00193-8.", "journal-title": "Gynecol Oncol"}, {"key": "1028_CR20", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1056/NEJM200107263450401", "volume": "345", "author": "B Modan", "year": "2001", "unstructured": "Modan B, Hartge P, Hirsh-Yechezkel G, Chetrit A, Lubin F, Beller U, Ben-Baruch G, Fishman A, Menczer J, Ebbers SM, Tucker MA, Wacholder S, Struewing JP, Friedman E, Piura B, National Israel Ovarian Cancer Study Group: Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med. 2001, 345: 235-240. 10.1056/NEJM200107263450401.", "journal-title": "N Engl J Med"}, {"key": "1028_CR21", "doi-asserted-by": "publisher", "first-page": "439", "DOI": "10.1023/A:1024932427503", "volume": "14", "author": "F Modugno", "year": "2003", "unstructured": "Modugno F, Moslehi R, Ness RB, Nelson DB, Belle S, Kant JA, Wheeler JE, Wonderlick A, Fishman D, Karlan B, Risch H, Cramer DW, Dube MP, Narod SA: Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States). Cancer Causes Control. 2003, 14: 439-446. 10.1023/A:1024932427503.", "journal-title": "Cancer Causes Control"}], "container-title": ["BMC Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/1471-2407-8-90.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/1471-2407-8-90/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/1471-2407-8-90", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 7, 9]], "date-time": "2016-07-09T12:24:07Z", "timestamp": 1468067047000}, "score": 12.700592, "issued": {"date-parts": [[2008, 4, 8]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2008, 12]]}, "issue": "1"}, "alternative-id": ["1028"], "URL": "http://dx.doi.org/10.1186/1471-2407-8-90", "relation": {"cites": []}, "ISSN": ["1471-2407"], "issn-type": [{"value": "1471-2407", "type": "electronic"}], "article-number": "90"}, {"indexed": {"date-parts": [[2018, 8, 13]], "date-time": "2018-08-13T15:22:37Z", "timestamp": 1534173757985}, "reference-count": 0, "publisher": "Springer Nature", "issue": "Suppl 4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hered Cancer Clin Pract", "Hereditary Cancer in Clinical Practice"], "published-print": {"date-parts": [[2012]]}, "DOI": "10.1186/1897-4287-10-s4-a6", "type": "journal-article", "created": {"date-parts": [[2012, 12, 10]], "date-time": "2012-12-10T11:15:50Z", "timestamp": 1355138150000}, "page": "A6", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Zinc and breast cancer risk"], "prefix": "10.1186", "volume": "10", "author": [{"given": "Katarzyna", "family": "Kaczmarek", "sequence": "first", "affiliation": []}, {"given": "Anna", "family": "Jakubowska", "sequence": "additional", "affiliation": []}, {"given": "Grzegorz", "family": "Sukiennicki", "sequence": "additional", "affiliation": []}, {"given": "Magdalena", "family": "Muszy\u0144ska", "sequence": "additional", "affiliation": []}, {"given": "Katarzyna", "family": "Jaworska-Bieniek", "sequence": "additional", "affiliation": []}, {"given": "Katarzyna", "family": "Durda", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Huzarski", "sequence": "additional", "affiliation": []}, {"given": "Pablo", "family": "Serrano-Fernandez", "sequence": "additional", "affiliation": []}, {"given": "Tomasz", "family": "Byrski", "sequence": "additional", "affiliation": []}, {"given": "Jacek", "family": "Gronwald", "sequence": "additional", "affiliation": []}, {"given": "Satish", "family": "Gupta", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Lubi\u0144ski", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Hereditary Cancer in Clinical Practice"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:12:19Z", "timestamp": 1463418739000}, "score": 12.700592, "issued": {"date-parts": [[2012]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012]]}, "issue": "Suppl 4"}, "alternative-id": ["1897-4287-10-S4-A6"], "URL": "http://dx.doi.org/10.1186/1897-4287-10-s4-a6", "ISSN": ["1897-4287"], "issn-type": [{"value": "1897-4287", "type": "print"}]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "HUZARSKI TOMASZ"}